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Abstract 
 
The elimination of a wide variety of infections requires the production of high 
affinity antibodies specific for the invading pathogen. The generation of these 
high affinity antibodies depends on the ability of B cells to recognise and 
internalise antigens from the surface of antigen-presenting cells (APCs) in an 
affinity-dependent manner. B cells expressing high affinity B cell receptors 
(BCRs) internalise, process and present more antigen, obtain better T cell help, 
and are selectively expanded over lower affinity equivalents. However, the 
molecular mechanisms by which B cells extract antigens for presentation remain 
unclear. 
 
Using a new fluid and flexible membrane substrate to mimic APCs, we show that 
B cells acquire antigen by dynamic myosin IIA-mediated contractions that pull out 
and invaginate the presenting membranes. Invaginations containing high affinity 
BCR-antigen microclusters were able to withstand the force of these contractions 
and recruit clathrin resulting in endocytosis. In contrast, low affinity BCR-antigen 
bonds quickly ruptured aborting internalisation.  
 
Thus we conclude that coupling contractility to endocytosis permits B cells to 
discriminate between antigen affinities, which provides a mechanism for the 
selective advantage seen for high affinity B cell clones in vivo.  
 
Disruptions in BCR-antigen internalisation has been linked to the growth of 
malignant B cells and the development of autoimmunity. Therefore, ultimately, 
our results could contribute to the effective design of future therapeutics for B cell 
diseases. 
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Chapter 1 Introduction 
 
1.1 The Immune System 
 
The immune system is a complex network of specialised cells, tissues and 
molecular components designed to efficiently recognise, control and clear 
infections. 
 
The immune system is comprised of innate and adaptive immune cells. Innate 
immune cells initially recognise patterns in the invading pathogens as “non-self” 
and initiate the immune reaction by the production of cytokines and chemokines, 
which activate other cellular members of the immune system and recruit them to 
the site of infection. Some innate cells such as macrophages and dendritic cells 
(DCs) are also able to present the peptides from the pathogen, or the pathogen 
itself in its native conformation, for recognition by T cells and B cells, 
respectively.  
 
T and B cells constitute the adaptive immune system and are able to “adapt” their 
responses to be specific for the infectious agent following recognition of antigen 
by their highly specialised antigen receptors. Each and every B cell receptor 
(BCR) and T cell receptor (TCR) is unique due to somatic recombination and 
introduction of point mutations into the genes encoding both receptors during 
development. This greatly increases the chances of antigen recognition of 
unforeseen pathogens, which may have evolved to evade detection by the innate 
immune cells. B and T cell clones, which bind to the antigen with high affinity, are 
then selectively expanded to elicit antigen-specific mechanisms of pathogen 
elimination and differentiate into memory cells in preparation for any subsequent 
reinfection. How B cells are able to initiate these antigen-specific responses will 
be the focus of this study. 
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1.2 BCR-antigen internalisation – an overview 
 
B cells begin their development in the bone marrow, and then migrate to the 
spleen to become fully mature naïve B cells primed for antigen encounter. B cells 
circulate in the blood and through secondary lymphoid organs in search of their 
cognate antigen. B cells bind to antigen in its native form and can recognise it 
both in solution and tethered to a cell of the innate immune system, which can act 
as an antigen-presenting cell (APC).  
 
B cells bind to antigen through the variable region of the membrane 
immunoglobulin (Ig) component of the BCR (Lanzavecchia, 1987) (Figure 1). 
Binding of antigen to the BCR stimulates antigen-induced BCR signalling through 
the cytoplasmic domains of the IgαIgβ heterodimer, which is non-covalently 
associated with membrane Ig (Figure 1) (Hombach et al., 1990). This signalling, 
switches on the B cell nuclear activation programme and acts as the first signal 
required for B cell activation.  
 
 
 
Figure 1: The BCR 
 
As well as initiating signalling, antigen binding stimulates the BCR to enter the 
endocytic pathway and internalise the BCR-antigen complex (Figure 2). The BCR 
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traffics the antigen to intracellular degradative compartments where it is 
degraded into peptides and loaded onto major histocompatibility complex class 
two molecules (MHC Class II) (Davidson et al., 1991) (Figure 2). These MHC 
class II proteins are then presented on the B cell surface for recognition by 
cognate T cells (Lanzavecchia, 1985). Specific recognition between TCR and 
MHC Class II-peptide permits the release of T cell co-stimulatory factors such as 
interleukins (IL) and CD40 ligand (CD40L) (Figure 2), which give context-
dependent stimulation and act as second signals required for full B cell activation 
and movement of the B cell into germinal centres (Han et al., 1995; Lane et al., 
1992; Parker, 1993). B cells in the germinal centre are highly proliferative and go 
through rounds of somatic hypermutation on their BCRs to increase diversity of 
the antigen binding. B cells containing mutations improving their affinity for 
antigen are selectively expanded, released into the circulation, and differentiate 
into plasma cells to produce high affinity antibodies for pathogen elimination, or 
into memory cells in preparation for any subsequent reinfection (Rajewsky, 1996; 
Victora and Nussenzweig, 2012). 
 
In addition to antigen processing and presentation, BCR-antigen internalisation 
also exposes antigen to endosomal toll-like receptors 7 and 9 (TLR7 and 9) 
(Figure 2), which are able to recognise RNA (Lau et al., 2005) and DNA (Bauer et 
al., 2001) sequences from viral and bacterial infections. Recognition of antigen by 
TLR7 or 9 can augment the B cell activation and aid pathogen recognition and 
clearance.  
 
BCR-antigen internalisation also has role in regulating BCR signalling, 
(Chaturvedi et al., 2011). For example, internalisation has been associated with 
the termination of calcium and MAP kinase activity and the promotion of AKT 
stimulation. Therefore, disregulation of BCR internalisation and trafficking may 
contribute to the inappropriate BCR signalling, which has been observed in B cell 
lymphomas (Davis et al., 2010).  
 
BCR-antigen internalisation is therefore the gateway for efficient B cell activation 
and stringent regulation of this process is vital in ensuring an efficient humoral 
response, while preventing pathology. 
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Figure 2: BCR-antigen internalisation 
A) BCRs can recognise antigen in solution  
B) BCRs can recognise antigen tethered to an APC 
C) Antigen binding initiates BCR signalling and stimulates the B cell’s nuclear activation 
programme (signal 1)  
D) Antigen binding stimulates internalisation of BCR-antigen complexes  
E) Internalised BCR-antigen complexes are trafficked to lysosomes, processed, and loaded 
onto MHC Class II molecules  
F) Antigen loaded MHC Class II molecules are presented on the B cell surface for specific 
recognition by cognate T cells  
G) Recognition of the antigen-loaded MHC Class II by T cells provides activation factors 
(signal 2)  
H) Internalisation of antigen also permits antigen recognition by intracellular pathogen 
recognitions receptors such as TLRs 
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1.3 Antigen encounter 
 
B cells primarily reside in the lymph nodes and the spleen. Considering the 
diverse range of the BCR repertoire, the chances of random contact between 
antigen and cognate B cell would be rare. Therefore secondary lymphoid organs 
are specifically structured to facilitate efficient antigen exposure to rare cognate B 
cells and to control cell-cell interactions (Batista and Harwood, 2009). In the 
lymph node, two areas can be identified based on their histological features: the 
cortex and the medulla. The cortex can be sub-divided into B cell follicles, which 
contains B cells, and the paracortex, also called the T cell zone, which contains T 
cells and DCs (Andrian and Mempel, 2003). The architecture of these regions is 
maintained by non-haematopoietic stromal cells such as fibroblastic reticular cells 
(FRCs) and follicular dendritic cells (FDCs). Apart from structural support, these 
cells also produce CXCL13 or CCL19, the defining chemokines that attract B and 
T cells to their respective zones (Andrian and Mempel, 2003; Gonzalez et al., 
2011).  
 
Lymph nodes are linked to both the lymphatic and circulatory systems and are 
strategically positioned around the body to ensure efficient trafficking and capture 
of lymphocytes arriving by blood and antigen draining from tissues (Batista and 
Harwood, 2009). B cells circulate around the body and enter the lymph nodes 
through the high endothelial venule (HEV). B cells then follow the CXCL13 
gradient and reside in the follicle just below the subcapsular sinus (SCS), at the 
site of lymphatic antigen entry (Cyster, 2010). Whilst screening for antigen in the 
follicle, B cells are active and migrate at approximately 6 µm/ minute (Okada et 
al., 2005). B cells are able to recognise both soluble antigen, which can filter into 
the follicle, or antigen retained on the surface of an APC (discussed below). 
Following specific antigen binding, B cells upregulate CCR7 (receptor for CCL19) 
and move towards the T cell zone for T cell help and the initiation of the B cell 
response (Okada et al., 2005). If the B cell does not come into contact with 
specific antigen after approximately 24 hours it re-enters the circulation in search 
of the next lymph node and cognate antigen (Goodnow, 1997). 
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The white pulp of the spleen is similar in its structure to the lymph node with B 
cell follicles and the T cell zone. Surrounding the white pulp is the red pulp, which 
is rich in vasculature and functions to filter blood for cellular debris, foreign 
substances, and microorganisms. An area called the marginal zone, containing 
specialised marginal zone B cells, macrophages, and DCs, controls the entry of 
blood-borne antigen from the red pulp into the white pulp and exposure to the 
residing lymphocytes (Mebius and Kraal, 2005).  
 
1.3.1 Soluble antigen encounter 
Soluble antigen can arise through the protease-mediated cleavage of larger 
microorganisms (Catron et al., 2010) or secreted bacterial products (Roozendaal 
et al., 2009), or alternatively, from an injection or vaccination. These soluble 
antigens drain into the lymphatic vessels and are carried in the lymphatic fluid to 
the lymph node. The lymph node itself is protected from the unregulated flow of 
soluble antigens into the cortex by the SCS, which separates the afferent 
lymphatic vessel and the B cell follicle (Gretz et al., 2000). However, it has been 
shown that B cells are able to respond to these soluble antigens indicating the 
presence of a controlled mechanism permitting the antigens to cross this barrier.  
 
Early electron microscopy images of the lymph node revealed small holes (0.1-1 
µm) in the lining of the SCS (van Ewijk et al., 1988) indicating the possibility that 
soluble antigen could filter through these holes into the follicle (Figure 3A). In 
support of this theory Pape et al 2007 intradermally injected hen egg lysozyme 
(HEL) antigen, tagged with green fluorescent protein (GFP), into the ears of 
recipient mice, which had previously been injected with HEL-specific MD4 B cells 
(Pape et al., 2007). Flash frozen cryosections of these lymph nodes 
demonstrated that MD4 B cells 150 µm away from the SCS and site of antigen 
entry, were able to acquire these antigens within minutes of injection. As B cells 
are unable to move more than approximately 6 µm/ minute without antigen, and 
are known to transiently decrease their mobility after specific antigen recognition 
(Okada et al., 2005), the authors suggest that antigen-positive B cells must have 
acquired antigen which diffused passively through the holes in the SCS. 
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More recently studies have shown that soluble antigens enter the B cell follicles 
through a conduit system (Figure 3A). Conduits are comprised of a core of 
collagen fibres surrounded by FRCs covering a basement membrane sheath. 
Conduits are abundant in the T cell zone, and in neonatal lymph nodes there are 
also ample levels in the B cell follicle, however during development, FDCs 
replace the majority of conduits in the B cell zone, leaving a much less dense 
network compared to the paracortex (Bajénoff and Germain, 2009). Using 
intravital imaging Roozendaal et al 2009 demonstrated that small soluble 
fluorescently-labelled turkey egg lysozyme (TEL) antigen injected 
subcutaneously into recipient mice, entered the lymph node in a centripetal 
fashion, highlighting the presence of a follicular conduit network (Roozendaal et 
al., 2009). Observations of B cells acquiring this antigen, and electron 
microscopy images showing B cell pseudopods directly sampling the antigen-
filled conduit core, demonstrated the use of these conduits in delivering antigen 
to B cells. The authors also revealed that if the TEL antigen was conjugated to a 
large fluorescent label (250 kDa), it was initially arrested at the SCS and then 
entered the lymph node with a delay. These findings mirror earlier studies 
showing that conduits have a size exclusion limit of 70 kDa (Gretz et al., 2000), 
and suggest that bigger antigens, require alternate mechanisms for entry into the 
follicle.   
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Figure 3: Antigen encounter in the lymph node 
A) B cells can encounter soluble antigen that has diffused through gaps in the SCS, or 
filtered into the follicle through the network of conduits 
B) Cognate or non-cognate B cells can bind to antigen transported over the SCS by SCS 
macrophages via their BCRs (red) or complement receptor (yellow), respectively. Non cognate B 
cells can then deposit the antigen on FDCs for later recognition 
C) DCs can bind to antigen in the periphery and transport it into the lymph through the HEV. 
DCs can then present antigen to B cells as they exit the HEV  
D) FDCs can retain antigen for a long time in the B cell follicle, and present it to B cells both 
before and during the germinal centre response 
 
1.3.2 Membrane-bound antigen encounter 
Although B cells can be activated by soluble antigen, the majority of antigen 
exposed to B cells during the immune response is bound to the surface 
membrane of APCs (Carrasco and Batista, 2006b). These APCs include 
macrophages, DCs and FDCs from the innate immune system.  
 
In vitro and in vivo studies have shown that B cell activation following membrane-
bound antigen encounter is more efficient than when exposed to a comparable 
soluble antigen (Batista et al., 2001; Huang et al., 2005; Qin et al., 1998; Wu et 
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al., 2008). This could be because of the expression of integrin receptors by the 
APC to facilitate long-lived and stable interactions with the cognate B cells (Allen 
and Cyster, 2008; Carrasco and Batista, 2006a; Carrasco et al., 2004). Or it 
could be because APCs concentrate and cluster antigen thereby increasing its 
avidity (Suzuki et al., 2009).  APCs can also augment B cell activation through 
stimulation of the B cell co-receptors or through the secretion of soluble survival 
and activation factors (Allen and Cyster, 2008; Balázs et al., 2002; Depoil et al., 
2007; Gonzalez et al., 2010a; Qin et al., 1998; Weber et al., 2008), as well as 
providing a platform for B-T cell interaction (Bergtold et al., 2005).  
 
As well as increasing B cell signalling and activation, APCs can also act as 
antigen transporters to ensure B cells are able to see antigen that cannot diffuse 
passively into the lymph node, and they can support the continual improvement 
of the humoral response during affinity maturation in the germinal centres 
following infection. 
 
1.3.3 The capture of antigen by antigen-presenting cells 
Before B cells can become activated by APCs, APCs must first capture antigen 
and retain it on the surface of their cell membrane. B cells need to be able to 
recognise bacteria, viruses, fungi, and parasites, as well as environmental or 
synthetic chemicals. Although APCs don’t need to recognise these antigens 
specifically, they do need to identify them as non-self so they can present them 
as pathogenic entities to the adaptive immune system. To be able to do this they 
have a selection of cell surface receptors to mediate this task. These include 
complement receptors and receptors which can recognise the Fc portions of 
soluble antibody, for example FcγRIIb receptors. These receptors recognise 
immune complexes, which are comprised of soluble antigen bound by natural or 
specific antibody and complement – complement are serum proteins which, when 
activated produce a protease cascade whose products bind to antigens and mark 
them for subsequent recognition by other components of the immune system 
(Bergtold et al., 2005; Carroll, 1998; Gonzalez et al., 2010a; Heesters et al., 
2013; Qin et al., 1998). Another important receptor group, which can mediate 
antigen presentation on APCs, are C-type lectins. These receptors can bind to 
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carbohydrate moieties of infectious agents such as viruses and yeast (Gonzalez 
et al., 2010c; Taylor et al., 2004).  
 
As BCRs recognise antigen in its native structure, APCs need to hold antigen in 
its native from. FcγRIIb and complement receptors have been shown able to 
internalise antigen into non-degradative endosomes and recycle them to their cell 
surface to allow stable and long-lived presentation of native antigen to B cells 
(Bergtold et al., 2005; Delamarre et al., 2005; Heesters et al., 2013).  
 
1.3.4 The transport of antigen by antigen-presenting cells to B cells 
As mentioned above, antigen can only diffuse into the lymph node if it is smaller 
than 70 kDa. Microorganisms such as viruses or bacteria are too big to filter into 
follicles, and small soluble protein antigens are thought to be quickly bound up 
into immune complexes by serum antibodies and complement. Therefore, APCs 
must transport these particulate antigens from the lymph into the follicle.  
 
One set of APCs able to mediate transport of antigen into B cell follicles are 
macrophages, which line the SCS. These SCS macrophages were first identified 
using light and electron microscopy as monocyte-type cells which were able to 
transfer immune complexes, produced through subcutaneous injection of antigen 
into passively immunised mice, across their cell surface and along their cell 
processes, which penetrated the B cell follicle (Szakal et al., 1983).  More 
recently, intravital imaging demonstrated that within minutes of subcutaneous 
injection of immune complexes, SCS macrophages are decorated with antigen, 
which can be directly presented to cognate B cells for specific recognition (Figure 
3B), resulting in B cell activation and movement to the B-T cell border (Carrasco 
and Batista, 2007; Phan et al., 2007). Studies using vesicular stomatitis virus as 
antigen, demonstrated that the disruption of SCS macrophages following 
clodronate liposomes treatment, prevented the initiation of an adaptive immune 
response and caused an increase in systemic viral load (Junt et al., 2007).  
 
Interestingly, non-cognate B cells have also been observed acquiring antigen 
from the SCS macrophages (Figure 3B). These B cells were able to bind to 
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antigen via their complement receptors and carry this antigen for deposition onto 
another family of APCs; FDCs, for later detection by cognate B cells (Heesters et 
al., 2013). The importance of non-cognate B cells transporting antigen was 
shown in both the spleen and lymph nodes of mice reconstituted with 
complement-receptor deficient B cells (Arnon et al., 2012; Cinamon et al., 2007; 
Ferguson et al., 2004; Phan et al., 2007). These mice had decreased antigen 
deposition on FDCs, which is required for germinal centre formation and 
maintenance, and therefore they also had a reduction in the subsequent humoral 
response. Although the ability of B cells to transport antigen has been known for 
a long time (Heinen et al., 1986), exactly how B cells are able to “give up” the 
antigen to FDCs is unknown, although reports suggest that the increased levels 
of complement receptor found on FDCs could outcompete the complement 
receptors on B cells (Carroll, 1998).  
 
DCs are also important in bringing antigen into the follicle or spleen for 
presentation to B cells (Figure 3C). DCs can bind to pathogens in the peripheral 
tissues or in the blood stream and bring them into the follicle or spleen to 
stimulate a B cell response (Balázs et al., 2002; Berney et al., 1999; Chappell et 
al., 2012; Qi et al., 2006; Wykes et al., 1998). This is especially important if the 
infecting microorganisms are large and may not enter the lymphatic drainage 
(Balázs et al., 2002; Manolova et al., 2008). Intravital imaging of DCs pulsed with 
soluble antigen and transferred into recipient mice, showed that they homed to 
the lymph nodes and crowded around the HEVs, to maximise the chance of 
cognate B cell encounter as they entered the lymph node (Qi et al., 2006). In 
addition to presentation of intact antigen important for B cell recognition, DCs 
also process and present antigen on MHC Class II molecules, which is important 
for antigen recognition by cognate T cells (Bergtold et al., 2005; Delamarre et al., 
2005). Expression of both processed and intact antigens facilitates cellular 
interactions between DCs, T cells and B cells and increases the efficiently of T 
cell help required for full B cell activation (Bergtold et al., 2005).  
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1.3.5 Antigen-presenting cells in maintaining the B cell follicle and 
supporting germinal centre function 
Another important APC involved in stimulating effective B cell responses in the 
lymph node are FDCs (Figure 3D). As with the macrophages and DCs, cognate 
interactions of B cells with antigen presented on these APCs leads to B cell 
activation (Heesters et al., 2013; Suzuki et al., 2009). Through the continual 
recycling of antigen via complement and FcγRIIb receptors, FDCs have been 
shown able to hold the antigen on their cell surface weeks after infection (Fang et 
al., 1998; Heesters et al., 2013; Schwickert et al., 2007; Suzuki et al., 2009; Wu 
et al., 2008). This long-lived antigen retention is particularly important in 
orchestrating the somatic hypermutation and clonal selection of high affinity B 
cells during the germinal centre response (Allen and Cyster, 2008; Chan and 
Brink, 2012; Wu et al., 2008).  
 
FDCs also have a role in maintaining the structural support of the B cell follicle 
and produce CXCL13 required to attract B cells to the follicle after entry into the 
lymph node (Cyster et al., 2000). Selective ablation of FDCs caused loss of 
structural integrity in the lymph node and the B cell follicles became disorganised 
bands of cells around the T cell zone (Wang et al., 2011).  
 
Collectively, these studies reveal intricate mechanisms ensuring that B cells can 
respond to antigen irrelevant of size or site of infection (Manolova et al., 2008) 
and with appropriate co-stimulatory signals. Loss or reduction of the humoral 
response when activity of these APCs or their antigen-binding receptors are 
disrupted, demonstrates the vital role of membrane-presented antigen for the 
development of an efficient antibody response (Fang et al., 1998; Gonzalez et al., 
2010b; Phan et al., 2007).  
 
1.4 B cell development 
 
Apart from B cell function in the periphery, BCR signalling is also instrumental 
during B cell development (Hardy and Hayakawa, 2001; Kurosaki et al., 2010; 
Mårtensson et al., 2010; Nagasawa, 2006; Wang and Clark, 2003). B cells 
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develop from common lymphoid progenitor cells and during this developmental 
process B cells interact with stromal cells, which give survival signals and 
developmental cues. The first B cell progenitor, the PrePro B cell (Figure 4), 
upregulates the cell surface marker B220. Following this, B cells move into the 
Pro B cell stage by upregulating the transcription factor Pax 5, which then 
stimulates Igα and CD19 surface expression, whilst the heavy chain locus of the 
BCR begins to rearrange (Nagata et al., 1997; Nutt et al., 1999; Wang and Clark, 
2003). Rearrangement of the variable, diverse and joining genes in the heavy 
chain locus is mediated by the Rag1/2 recombinase, and then non-templated 
nucleotides are inserted into joints of the newly rearranged gene segments by 
deoxynucleotidyl transferase. Expression of a newly-rearranged signalling-
competent Pre-BCR (Igµ paired with surrogate light chains) on the cell surface, is 
required for the transition from the Pro B cell stage into Pre B cell stage and is 
followed by proliferation (Gong and Nussenzweig, 1996; Kitamura et al., 1991; 
Pelanda et al., 2002) (Figure 4). Although it is possible that ligand-induced BCR 
signalling could mediate this proliferation stimulation, it has been widely 
suggested that this signal is BCR intrinsic and depends on the unique clustering 
properties of the surrogate light chains (Mårtensson et al., 2010; Ohnishi and 
Melchers, 2003).  Light chains of the BCR are then rearranged producing an 
immature B cell.  
 
 
 
Figure 4: B cell development 
Stage 1: PrePro B cells develop from common lymphoid progenitors in the bone marrow and 
interact with CXCL12 expressing stromal cells  
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Stage 2: Pro B cells interact with IL-7 expressing stromal cells and upregulate the IgαIgβ 
heterodimer, which signals for transcription and rearrangement of Igµ heavy chain  
Stage 3: Pre B cells express Igµ heavy chain with surrogate light chains, which stimulates 
proliferation of the B cell and light chain rearrangement  
Stage 4: Immature B cells express a fully assembled BCR, which stimulates B cell clonal deletion, 
BCR rearrangement, or release into the periphery  
Stage 5: Mature B cells enter circulation 
 
Immature B cells undergo negative selection, which depends on BCR-mediated 
recognition of autoantigens and is thought to prevent autoreactive B cells from 
entering the periphery. This was shown in MD4 mice whose B cells are specific 
for HEL and which were also engineered to express HEL tethered to stromal 
cells, as they had no peripheral B cells (Hartley et al., 1991). A similar phenotype 
was seen after the introduction of an anti-DNA BCR transgene into non-
autoimmune mice (Chen et al., 1994). Separately, physical crosslinking of BCRs 
on immature B cells in vitro by αIgM antibodies, stimulated immature B cells to 
die (Norvell et al., 1995).  
 
However, although these studies show the requirement for effective BCR 
signalling following autoantigen binding in sorting out the autoreactive B cells, we 
still don’t know in what form the developing B cells recognise the autoantigens 
and whether some specialised APCs are involved. It is also unknown whether 
this developmental step requires BCR-antigen internalisation or whether cell-
surface BCR crosslinking is sufficient. It has been shown that mutations in TLR-
signalling pathways result in defects in negative selection, suggesting a 
possibility that antigen internalisation and trafficking to TLR-containing 
compartments may play an important role (Isnardi et al., 2008). Therefore, the 
role of antigen internalisation from APCs and APC-B cell interaction in B cell 
development is an interesting topic for future study. 
 
1.5 BCR signalling  	  
1.5.1 BCR signalling in the absence of antigen 
Once B cells become mature and populate the periphery, they require 
constitutive BCR signalling even in the absence of antigen. This was shown by 
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the apoptotic loss of B cells following inducible Cre-mediated deletion of the 
heavy chain of the IgM, or deletion or mutation of Igα in peripheral B cells (Kraus 
et al., 2004; Lam et al., 1997). This loss of mature B cells was restored by 
constitutive PI3 kinase signalling, indicating that BCRs signal through this 
pathway to regulate B cell survival (Srinivasan et al., 2009). 
 
The exact trigger for the survival signalling from the BCR is not well understood. 
It was originally hypothesised that these survival signals were initiated from the 
exposure of BCR to low levels of ligand or self antigen, or through spontaneous 
BCR tonic signalling (Kraus et al., 2004; Lam et al., 1997; Reth and Wienands, 
1997). More recently, signalling in response to BAFF has been implicated. BAFF 
is a cytokine, which binds to its receptor (BAFFR) on the surface of follicular and 
marginal zone B cells. This binding induces BAFFR-mediated signalling, critical 
for B cell survival (Mackay et al., 2010). Inducible deletion of the BCR or the 
BCR-proximal signalling molecule Syk, led to unresponsiveness of B cells to 
BAFF and B cell death (Schweighoffer et al., 2013). These studies suggest that 
in this context the BCR can act as an adaptor protein in the BAFFR signalling 
pathway and functions following BAFFR-mediated phosphorylation of its Igα 
chain, by activating Syk and subsequently PI3 kinase (Schweighoffer et al., 
2013).  
 
1.5.2 Antigen-induced BCR signalling  
The first biochemical steps after antigen binding to the BCR is phosphorylation of 
immunoreceptor tyrosine-based activation motifs (ITAM) found in the cytoplasmic 
domains of the IgαIgβ heterodimer by Src and Syk family tyrosine kinases (Dal 
Porto et al., 2004).  Exactly how this is happens is a matter of debate. Three 
possible scenarios have been suggested recently.  
 
Firstly, total internal reflection fluorescence (TIRF) imaging of labelled BCRs has 
shown that in the absence of antigen approximately 80% of BCRs are monomeric 
and freely diffuse on the plasma membrane (Tolar et al., 2005). This was 
demonstrated using fluorescence energy resonance transfer (FRET) analysis of 
BCR components labelled with FRET donor or acceptor proteins. In the absence 
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of antigen a very low FRET signal was observed between labelled components 
suggesting the majority of BCRs were not in close enough proximity to elicit a 
FRET signal. However, after antigen binding the FRET signal dramatically 
increased clearly illustrating the formation of oligomers, and then decreased 
suggesting ‘opening’ of the BCR cytoplasmic domain. This decrease in FRET did 
not reach levels seen without antigen, and coincided with the recruitment and 
activation of signalling molecules to the BCR (Tolar et al., 2005).  
 
Targeted deletion of IgM segments identified the Cµ4 domain as the part 
responsible for mediating the change from monomer to oligomer. BCRs missing 
this portion were unable to oligomerise and could not signal in response to 
membrane-bound monovalent antigen, and constructs containing Cµ4 alone 
spontaneously clustered and signalled independently of antigen. These studies 
suggest that following antigen binding the BCR alters its conformation through 
the Cµ4 domain, facilitating oligomerisation. Once oligomerised, the cytoplasmic 
domain of the BCR opens permitting interactions with signalling molecules and 
initiating the activated-BCR signalling cascade. (Tolar et al., 2009b).  
 
Secondly, it has been suggested that BCRs are inactive oligomers at rest 
(Schamel and Reth, 2000) and activated BCR signalling is prevented by auto-
inhibition of the cytoplasmic domains. Binding of multivalent antigen then forces 
these oligomers apart into monomers, freeing the cytoplasmic domains to initiate 
signalling (Yang and Reth, 2010). Oligomerisation was recently demonstrated 
using confocal microscopy and bifluorescent complementation. Components of 
the BCR were tagged with either the N- or C- terminal of yellow fluorescent 
protein (YFP) and if the components came close enough together i.e. following 
dimerisation, a fluorescent signal was generated. In these studies a YFP signal 
was detected without antigen, suggesting oligomers were present on the cell 
surface. However it is difficult to understand the functionality of these oligomers 
as the bifluorescent interaction is irreversible, and therefore does not take into 
account the possibility of transient association due to the high number of BCRs 
found on the B cell surface. These studies also indicate that for BCRs to become 
fully activated, a multivalent antigen is needed to hold the BCRs apart, which 
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does not accommodate the results demonstrating BCR activation following 
stimulation with membrane-bound monovalent antigens (Tolar et al., 2009b). 
However, the percentage of total BCRs held in these oligomers was not 
assessed, and therefore could account for the 20% of immobile BCRs seen in 
other studies (Tolar et al., 2005; Treanor et al., 2010).  
 
The third theory suggests that interactions between the Igβ chain and actin 
cytoskeleton allow the BCRs to diffuse freely in the membrane but in regions 
defined by cytoskeleton (Treanor et al., 2010). These actin-defined regions are 
thought to prevent the association of activating kinases or deactivating 
phosphatases, required for antigen-induced signalling. This was shown by the 
initiation of BCR signalling, comparable to that elicited by antigen binding, 
following cytoskeleton disruption (Treanor et al., 2010; 2011).  
 
Within these defined regions BCRs were observed in nanoclusters containing 
approximately 30-150 IgD or 25-50 IgM molecules, using direct stochastic optical 
reconstruction microscopy (dSTORM) (Mattila et al., 2013). dSTORM allows the 
visualisation of BCRs at a much higher accuracy of 20 nm compared to 200 nm 
for TIRF and confocal microscopy (Pierce and Liu, 2010) used in the earlier 
studies. Whether these nanoclusters can mediate activated BCR signalling 
individually, or possibly could join with other nanoclusters to produce larger 
signalling-active microclusters, is not yet clear. Also it is not possible to conclude 
whether these nanoclusters are oligomers mediated by direct protein-protein 
interactions, or whether they are individual BCRs localised in close proximity 
(Mattila et al., 2013). One of the limitations of dSTORM is that it is carried out on 
fixed cells, which does not account for the dynamic nature of BCRs. Therefore 
the change in BCR organisation from resting and tonic, to antigen-bound and 
activated, is still open for debate. 
 
1.5.3 Translocation to lipid rafts  
Once the BCR has bound antigen, BCR-antigen complexes (whether oligomers, 
monomers or nanoclusters) decrease their rate of diffusion (Tolar et al., 2005; 
Treanor et al., 2011), group together to form microclusters, and translocate to 
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detergent-insoluble cholesterol-rich lipid rafts (Cheng et al., 1999; Sohn, 2006; 
Sohn et al., 2008). How the antigen-bound BCR moves to the lipid rafts is also 
unknown. The conformational change through the Cµ4 domain may alter the 
structure of the BCR so that dwelling in the lipid rafts is more energetically 
favourable (Tolar et al., 2009a), which could explain studies showing BCR-
antigen translocation to lipid rafts independently of actin or canonical BCR 
signalling (Cheng et al., 2001). Alternatively, other studies suggest that this 
movement is dependent on actin activity stimulated by BCR binding to antigen. 
This insinuates some form of very early BCR signalling even before the BCR 
comes into contact with its established signalling mediators (Dal Porto et al., 
2004; Treanor et al., 2011). Once in the lipid rafts, BCR microclusters can 
interact with Lyn, a Src family tyrosine kinase, which resides in the lipid rafts 
(Sohn et al., 2008). IgαIgβ ITAM phosphorylation by Lyn then recruits and 
activates Syk, which initiates the BCR signalling cascade (Bonnerot et al., 1995; 
Dal Porto et al., 2004; Ma et al., 2001). This antigen-induced signalling cascade 
stimulates many intracellular signalling pathways, which lead to a multitude of 
outcomes including B cell proliferation, survival, differentiation as well as 
internalisation and presentation of antigen. (Dal Porto et al., 2004; Kurosaki et al., 
2010).  
 
1.5.4 Synapse formation in response to membrane-bound antigen 
The majority of antigen in vivo will be tethered to an APC, and in vitro studies 
have suggested that once B cells recognise membrane-bound antigen they form 
BCR-antigen microclusters arranged in an immunological synapse (Batista et al., 
2001). To study the molecular requirements for this process, antigen tethered to 
planar lipid bilayers (PLB), has been used as a surrogate for APCs (Figure 5). 
PLB are very flat structures and together with TIRF microscopy allow high-
resolution 2D imaging of molecular events occurring at the plasma membrane, 
which cannot be achieved in vivo (Pierce and Liu, 2010). 
 
The formation of BCR-antigen microclusters, and the initiation of BCR signalling 
in response to PLB-bound antigen, stimulates F-actin dependent B cell spreading 
over the antigen-presenting surface (Figure 5A and B) (Fleire et al., 2006). As the 
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B cell spreads it continues to bind to antigen and form new BCR-antigen 
microclusters (Figure 5B), and then contracts bringing them into a central 
supramolecular activation cluster (Figure 5C), reminiscent of those found in T cell 
synapses (Fleire et al., 2006; Grakoui et al., 1999). The extent of B cell 
spreading, and therefore the final amount of antigen collected in the synapse, 
correlates with antigen affinity, and in order for B cell spreading to be initiated, a 
minimum affinity threshold must be attained (Fleire et al., 2006; Liu et al., 2010). 
This threshold can be lowered by increasing the avidity of the antigen (Tolar et 
al., 2009b), or by the presence of the integrin receptors LFA-1 and VLA-4, as well 
as through association with the BCR co-receptor CD19 (Arana et al., 2008; 
Carrasco and Batista, 2006a; Carrasco et al., 2004; Depoil et al., 2007; Lin et al., 
2008). These findings confirm the roles for APC co-stimulatory factors mentioned 
earlier.  
 
 
 
Figure 5: B cells form synapses with antigen-presenting surfaces 
A) B cells bind to antigen via their BCRs 
B) B cells spread over the antigen-presenting surface forming signalling-active BCR-antigen 
microclusters  
C) B cells contract, bringing the BCR-antigen microclusters into a mature immunological 
synapse 
 
Individual protein knockout studies in the DT40 chicken B cell line, showed 
signalling from Lyn and Syk, was required for B cells to adhere to the PLB, 
whereas synergistic activity between the more distal BCR signalling molecules, 
PLCγ and Vav, mediated spreading (Weber et al., 2008). Less is known about 
the process of contraction, and although it is understood to be F-actin dependent 
(Arana et al., 2008; Fleire et al., 2006; Lin et al., 2008),  more recently, the 
involvement of the microtubule network has been implicated (Schnyder et al., 
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2011). This was shown by the recruitment of the microtubule-motor Dynein to the 
contracting microclusters by a Grb2-Dok3-cbl complex.  
 
1.6 BCR-antigen internalisation 
 
While the formation of signalling active BCR microclusters immediately after 
antigen binding has been extensively observed in vitro in response to multivalent 
soluble antigen (Ma et al., 2001; Niiro et al., 2004) as well as both monovalent 
and multivalent PLB-bound antigen (Depoil et al., 2007; Fleire et al., 2006; Liu et 
al., 2010; Weber et al., 2008). How BCR-antigen microclusters are internalised 
remains unclear. 
 
Studies have shown that BCR signalling is required for efficient antigen 
internalisation, suggesting a crosstalk between BCR signalling and endocytic 
machinery. For instance, antigen internalisation has been shown to be dependent 
on the signalling capacity of the BCR’s IgαIgβ cytoplasmic domains. Using 
chimera constructs containing the cytoplasmic domains of either the Igα or the 
Igβ proteins, studies have shown that both chains contained residues that could 
individually mediate BCR internalisation (Bonnerot et al., 1995; Jang et al., 2010; 
Lankar et al., 1998). Point mutation studies have also shown that activity from 
both ITAM (Cassard et al., 1998; Gazumyan et al., 2006) and non-ITAM tyrosines 
within the IgαIgβ heterodimer (Hou et al., 2006; Patel and Neuberger, 1993) are 
required for this process. 
 
Similarly, BCR proximal signalling molecules have been connected to this 
process. Antigen-stimulated Lyn knockout B cells were inhibited in their ability to 
internalise antigen, shown by retention of antigen on the cell surface (Chan et al., 
1998; Ma et al., 2001). Downstream of Lyn, BCR signalling also activates 
regulators of the actin cytoskeleton, and a role for actin polymerisation in BCR-
antigen internalisation has been proposed. For example, results from knockout 
and inhibitor studies on Bam32 (Niiro et al., 2004) and WASp (Becker-Herman et 
al., 2011) showed similarities in phenotype to Lyn knockout cells, and BCR-
antigen internalisation is also reduced following disruption of Vav mediated 
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activation of Rac (Malhotra et al., 2009a; 2009b). Consistently with these studies, 
disruption of actin polymerisation itself also decreased BCR-antigen 
internalisation (Stoddart et al., 2005).  
 
The primary endocytic mediator involved in BCR-antigen internalisation is 
thought to be clathrin. This was first shown by early electron microscopy studies, 
which demonstrated the endocytosis of antigen-bound BCRs through clathrin 
coated pits (Salisbury, 1980). More recently this has been supported by a 
correlation between BCR-antigen internalisation and lipid raft-associated clathrin 
phosphorylation, and a reduction in BCR-antigen internalisation after the 
inducible deletion of the clathrin heavy chain in DT40 cells. These studies use 
biochemical analysis to propose that antigen-induced BCR signalling stimulates 
phosphorylation of clathrin within the lipid raft scaffold initiating internalisation 
(Stoddart et al., 2002; 2005). Clathrin-mediated endocytosis is dependent on the 
recruitment and organisation of an array of specific adaptor proteins to the site of 
clathrin coated pit formation. Some of these adaptors are indispensible for 
clathrin action such as AP2, but others can vary depending on the cargo, cell 
type or environment (McMahon and Boucrot, 2011; Taylor et al., 2011). However, 
to date, the involvement of any cargo-specific adaptors required for BCR-antigen 
internalisation through clathrin-mediated endocytosis, remains unknown. 
 
Although studies of BCR-antigen internalisation have identified roles for BCR 
signalling, lipid rafts, the actin cytoskeleton, and clathrin-mediated endocytosis, 
they have also indicated a significant level of redundancy in this process. Some 
studies suggest that lipid rafts act as a signalling platform only and antigen-bound 
BCRs are not internalised from these structures (Hou et al., 2006; Putnam et al., 
2003). Also, deletion of clathrin, inhibition of actin activity or disruption of lipid raft 
heterogeneity, does not completely abolish BCR-antigen internalisation (Stoddart 
et al., 2005), suggesting alternative mechanisms can partially compensate for 
their loss. In addition, it is unknown whether the same components are required 
for internalisation of membrane-bound antigen as described for antigen in 
solution. In fact, the almost absolute requirement for actin activity for synapse 
formation in response to membrane-bound antigen (Fleire et al., 2006), 
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compared to a redundant role when faced with soluble antigen (Stoddart et al., 
2005), suggests that the two internalisation processes may be different.  
 
Therefore, although key players in BCR-antigen internalisation have been 
identified, their precise contribution and mechanism of action, and how they 
interlink together, requires further study. 
 
1.7 Affinity-dependent antigen internalisation 
 
B cells need to be able to internalise antigen in an affinity-dependent manner as 
affinity-dependent BCR-antigen internalisation allows the selective expansion of 
high affinity B cell clones. These B cells can then produce high affinity antibody, 
specific for the invading pathogen, marking it for elimination. This happens at two 
primary checkpoints of the B cell response. Firstly, at the point of antigen 
encounter in the B cell follicle to provide an immediate antibody response (Paus 
et al., 2006), and secondly during affinity maturation in the germinal centre to 
encourage the expansion of high affinity B cells and their differentiation into 
plasma cells and memory B cells (Chan and Brink, 2012; Rajewsky, 1996).  
 
In vitro studies have shown that B cells can recognise and discriminate between 
a range of different antigen affinities (Batista and Neuberger, 1998). B cells 
respond with increasing efficiency to soluble monovalent antigen with affinities 
from Ka > 106 M-1 up until Ka > 1010 M-1, where an affinity ceiling threshold is 
reached and the corresponding B cell response does not continue to grow 
irrelevant of any further increases in affinity (Batista and Neuberger, 1998). This 
increased B cell response to high antigen affinity was shown firstly at the level of 
BCR signalling by increased levels of calcium flux and phosphorylation of early 
BCR signalling mediators (Kouskoff et al., 1998), and secondly at the level of 
antigen presentation by higher levels of IL-2 production by cognate T cell specific 
hybridomas, which had been co-cultured with MD4 B cells and HEL antigens 
(Batista and Neuberger, 1998).  
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Similar dependence on affinity has been shown for membrane-tethered antigens. 
TIRF microscopy of antigen-loaded PLB revealed that cognate B cells had 
increased levels of spreading, microcluster formation, and subsequent antigen 
accumulation and synapse formation, when BCRs of high affinity were settled on 
the same antigen compared to the lower affinity equivalent BCR (Fleire et al., 
2006; Liu et al., 2010). Taken together these studies suggest that high affinity 
monovalent antigen stimulates a greater level of signalling and BCR-antigen 
accumulation, which results in a higher level of antigen internalisation and 
presentation, and subsequent cognate T cell activation.  
 
However, these measurements and studies only look at an individual reaction 
between a single Fab molecule of the BCR and a single epitope in the antigen. In 
vivo, considering the bivalent nature of the BCR, and the multivalency of antigen 
associated with the infections B cells must recognise, such as bacteria, viruses, 
fungi, and parasites, the majority of interactions between the BCR and the 
antigen will be multivalent. This means that B cell recognition of antigen is also 
affected by avidity (number of bonds between BCRs and antigen). High avidity 
antigen can be formed not only through the particulate nature of the antigen itself 
but also through complexing of antigen with natural antibodies or complement in 
the blood stream, or by clustering on the surface of APCs as mentioned earlier 
(Batista et al., 2001; Chan and Brink, 2012; Gonzalez et al., 2010a). In vitro, 
increasing the avidity of antigen raises its immunogenicity above the threshold 
required for maximum B cell stimulation, which prevents B cells from 
discriminating between antigen affinities in solution (Batista and Neuberger, 
2000). However, in vivo, where antigens are primarily displayed on APCs, B cells 
respond to antigen in an affinity-dependent manner (Batista and Neuberger, 
2000; Chan and Brink, 2012; Schwickert et al., 2011; Shih et al., 2002a; 2002b; 
Wan et al., 2013).  
 
Observations of adoptively transferred B1-8 B cells with either a high or low BCR 
affinity for the nitrophenyl hapten (NP) into immunised recipient mice, showed 
that the rate of antigen internalisation and subsequent presentation correlated 
with affinity. This difference in internalisation rate didn’t cause the observed 
affinity discrimination itself, as when low affinity B cells were transferred alone, 
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they were able to elicit a normal B cell response (Schwickert et al., 2011). Only 
when competition was introduced by transferring both high and low affinity B cells 
together, was there affinity discrimination and an almost exclusive expansion of 
high affinity clones which dominated the majority of the germinal centre response 
(Schwickert et al., 2011; Shih et al., 2002a). This was due to the increased levels 
of presented antigen on high affinity B cells, which monopolised T cell help at the 
B-T cell boarder and prevented lower affinity B cells from receiving the correct 
survival signals (Schwickert et al., 2011). Thus affinity discrimination at the B-T 
cell border selects BCRs with the relatively highest affinity to enter into the 
germinal centre (Schwickert et al., 2011). This relative selection mechanism, 
therefore, allows antigens of low affinity to still produce a successful immune 
response (Dal Porto et al., 1998; 2002), which is particularly important in the case 
of a primary infection, when the typical affinity of the BCR for a previously unseen 
pathogen is low (Chan and Brink, 2012). 
 
Once in the germinal centre, B cells cycle between the light and dark zones. 
Within the dark zones B cells proliferate and activate somatic hypermutation. 
Somatic hypermutation introduces point mutations into the variable region of the 
BCR, diversifying the affinity for the stimulating antigen (Jacob et al., 1991; 
McKean et al., 1984). After one or more rounds of division B cells move to the 
light zone and test the fitness of the newly mutated BCR by binding to antigen 
displayed by light zone-resident FDCs (Allen and Cyster, 2008; Victora and 
Nussenzweig, 2012). B cells with a higher affinity are thought to internalise more 
of the antigen and present more to follicular helper T cells (Tfh) (Khalil et al., 
2012; Victora et al., 2010). This T cell help has again been shown to be limiting 
and only those B cells with high enough affinity for the antigen receive T cell help, 
which stimulates not only their survival but also their movement back into the 
dark zone to continue another round of proliferation and somatic hypermutation 
(Victora et al., 2010). This mechanism ensures the continual selective expansion 
of high affinity B cells as the immune response progresses (Jacob et al., 1991; 
Rajewsky, 1996). In contrast, low affinity B cells internalise less antigen from 
FDCs, receive less help from Tfh, accumulate in the light zone, and die. 
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New studies by Khalil et al 2012 have recently provided evidence showing that 
BCR signalling in the germinal centre reaction is inhibited by phosphatase 
activity, which may favour internalisation and presentation of the antigen to Tfh 
and possibly augments high affinity B cell expansion (Khalil et al., 2012).  
 
Some antigens are highly stimulative to B cells and do not require T cell help to 
elicit antibody production; these are called T cell-independent (TI) antigens. TI 
antigens are usually large, polyvalent structures with repeating patterns such as 
carbohydrates from a bacterial capsid or virus. The polyvalent nature of these TI 
antigens allows extensive crosslinking of BCRs, which augments B cell signalling 
and intrinsically provides the stimulation needed for B cell activation and 
proliferation (Vos et al., 2000). These responses differ from T cell-dependent 
antigens as they do not form germinal centres, and function to quickly release 
soluble antibody against circulating pathogens (Shih et al., 2002b). Despite the 
lack of T cell help when faced with TI antigens, high affinity B cell clones are still 
able to outcompete low affinity clones. It is unclear how this competition happens, 
but it is possible that high affinity B cells internalise antigen more quickly, which 
in turn stimulates faster B cell proliferation, increases access to other stimulatory 
factors such as cytokines, and therefore facilitates the selective expansion of 
high affinity B cell clones.  
 
The ability of B cells to internalise antigen in an affinity-dependent manner is vital 
during the immune response. This is important both at the point of initial antigen 
encounter, and to support the continual improvement of BCR affinity in germinal 
centres as the immune response progresses. Collectively, these studies show 
that the ability of B cells to discriminate between antigen affinities is due to the 
increased rate of antigen internalisation of high affinity B cells. However, the 
molecular mechanisms controlling this process are still unknown. 
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1.8 Defects in membrane-bound antigen internalisation can 
lead to autoimmunity or cancer 
 
BCR-antigen internalisation is a tightly regulated process to ensure effective B 
cell function, and disturbances have been linked to B cell-mediated autoimmune 
diseases and cancer. These diseases can be a result of a range of either genetic 
factors, such as mutations in negative regulators of BCR signalling or they can be 
induced by the environment, for example by B cell responses to infection that 
cross-reacts with self-components. It is, therefore, important to consider how 
BCR-antigen internalisation prevents pathology, and how disturbances in this 
process can cause these diseases. 
 
1.8.1 Autoimmunity 
70% of newly developed immature B cells are autoreactive and have the 
potential to cause autoimmune pathologies by the production of autoantibodies 
specific for self-proteins, which then target self-cells for destruction (O'Neill et al., 
2011; Plotz, 2003).  
 
B cell interactions with APCs, in addition to their function in stimulating B cell 
activation, are also important in deleting these autoreactive B cells. Membrane-
bound autoantigen is more efficient at this deletion than comparable soluble 
autoantigen. For example, during development, cognate B cells, which react with 
autoantigen expressed by stromal cells, are deleted and prevented from exiting 
the bone marrow, whereas their reaction to soluble autoantigen induces antigen-
unresponsiveness (anergy) in the B cells, but they are still permitted to reach the 
periphery (Goodnow et al., 1988; Hartley et al., 1991). A similar deletion is seen 
after encounter with membrane-bound autoantigen in the periphery, which 
demonstrates an additional layer of control to ensure deletion of B cells specific 
for an autoantigen that is not present in the bone marrow (Russell et al., 1991; 
Taylor et al., 2012).  
 
In the germinal centre, there is a risk that the newly mutated BCRs may cross-
react with autoantigen and become autoimmune.  Antigen presented by APCs in 
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the germinal centre can communicate to the B cell that the antigen is pathogenic 
and not self. This was shown by the rapid deletion of B cell clones in the germinal 
centre when soluble antigen, representing autoantigen, was added (Chan et al., 
2012; Pulendran et al., 1995; Shokat and Goodnow, 1995).  
 
Therefore, disruptions in the molecules that facilitate B cell-APC interaction, can 
lead to inappropriate activation of these B cells and the development of 
autoimmunity. For example, chronic expression of the integrins LFA-1 and VLA-
4, which reduce the B cell activation threshold by facilitating adhesion between B 
cells and APCs, could promote B cell activation to low affinity autoantigens which 
should not normally stimulate a B cell response (Carrasco and Batista, 2006a; 
Carrasco et al., 2004). In addition, elevated expression of CD19, the BCR co-
receptor shown to augment B cell activation in response to membrane-bound 
antigen (Depoil et al., 2007), has also been linked to an autoimmune phenotype 
by B cell hyper-responsiveness and autoantibody production (Hasler and Zouali, 
2001). Conversely, loss of inhibitory factors, which prevent B cell response to 
autoantigens, can also cause autoimmunity. This was shown following the loss of 
CD22. CD22 is a receptor for α2,6 sialogglycoconjugates, which are commonly 
expressed on cell types which B cells are likely to encounter in an infection 
setting i.e. other lymphocytes and activated endothelium (Lanoue et al., 2002). 
The interaction between CD22 and α2,6 sialogglycoconjugates is thought to 
inhibit antigen-bound BCR signalling and reduce the expression of the B cell 
activation markers CD69 and CD86. As a result, B cells deficient in this BCR 
negative regulator, are prone to the production of autoantibodies and the initiation 
of autoimmune disease (O'Keefe et al., 1999; 1996).  
 
Autoimmunity can also be caused by disturbances in BCR signalling, which 
normally controls antigen internalisation. Surprisingly, both Lyn knockout and Lyn 
gain of function mice are prone to autoimmune phenotypes characterised by 
hyper-responsive B cells and an increase in autoantibody production (Chan et al., 
1997; Hibbs et al., 2002). It is difficult to ascertain how much of this phenotype is 
due to loss of internalisation as Lyn’s role in B cell activation goes beyond 
stimulating internalisation. Lyn activity is required for phosphorylating both 
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positive and negative BCR regulators (Xu et al., 2005). Therefore when Lyn is 
lost, so is the activation of molecules, which inhibit B cell activation such as 
CD22, FcγRIIb, and SHIP-1 (Chan et al., 1998; O'Neill et al., 2011), and when 
Lyn is over expressed BCR activating molecules such as Syk are increased 
(Hibbs et al., 2002). These studies illustrate the complexity of BCR signalling and 
internalisation, and clearly demonstrate the difficulties in elucidating the exact 
mechanism and role of BCR-antigen internalisation in vivo.  
 
One of the ways B cells prevent autoimmunity is through the process of anergy. 
Anergy is a non-reactive state of B cells, which occurs following recognition of 
autoantigen during development or in the periphery. Anergy can be initiated 
through chronic low-level stimulation of BCRs without T cell help (Cambier et al., 
2007; O'Neill et al., 2011), but can also be controlled at the level of BCR-antigen 
internalisation. For example, when anergic B cells recognise DNA-containing 
autoantigens, they do not recruit TLR9 for amplification of the B cell response, 
but prevent antigen from meeting TLR9 before merging into late endosomes 
(O'Neill et al., 2009). However this altered trafficking in anergic B cells is reverted 
in autoimmune B cells, possibly by BCRs mistaking hypomethylated DNA from 
apoptotic cells for bacterial DNA (Leadbetter et al., 2002), or over active TLR9 
signalling (Christensen, 2005). This results in the recruitment of TLR9 to 
internalised BCR-antigen complexes (Chaturvedi et al., 2008) and production of 
autoantibodies against self-DNA (Viglianti et al., 2003).   
 
It has also been suggested that accelerated BCR-antigen internalisation from 
lipid rafts may help to maintain the unresponsiveness of anergic B cells. Studies 
showed that anergic B cells have a large intracellular pool of BCRs, present in a 
recycling endosomal compartment (Bléry et al., 2006). These anergic B cells had 
a faster rate of internalisation compared to naïve B cells, which prevented 
initiation of the signalling pathway leading to NFκB activation and subsequently B 
cell activation through the transcription of factors such as c-myc and bcl-XL. If 
lipid rafts were disrupted in these anergic cells by methyl-β-cyclodextrin, then 
BCRs quickly relocated to the cell surface and regained their responsiveness to 
antigen. 
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1.8.2 Cancer 
In addition to antigen processing and engagement of antigen with intracellular 
TLRs, BCR-antigen internalisation also functions to alter BCR signalling to 
prevent the inappropriate survival of B cells, which could lead to cancer. Inhibition 
of BCR-antigen internalisation has been shown to maintain activate antigen-
induced signalling complexes at the cell surface, which downregulates 
transcription factors controlling proapoptotic genes, and promotes B cell survival 
(Chaturvedi et al., 2011; Srinivasan et al., 2009).  
 
This inhibition of internalisation together with the resulting hyper-responsive BCR 
signalling is seen in activated B cell like subtype of diffuse large B cell lymphoma 
cells (ABC DLBCL) (Davis et al., 2010). This is thought to be caused by 
mutations in the IgαIgβ ITAMs frequently found in ABL DLBCL biopsies. These 
mutations were shown to prevent the full activity of Lyn and inhibitory 
phosphatases, and inhibited BCR internalisation, causing a malignant phenotype.  
 
These studies collectively show that although BCR-antigen internalisation is vital 
in the production of high affinity antibodies required for specific pathogen 
elimination, it is also important in preventing inappropriate B cell survival or B cell 
activation to autoantigens that could lead to the development of cancer or 
autoimmunity. By understanding how BCR-antigen internalisation works in 
normal physiology we hope to better understand how these processes are 
disregulated in disease. This knowledge could potentially be applied in the 
manipulation of BCR internalisation in order to treat B cell diseases. 
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1.9 Thesis Aims 
 
It is well acknowledged that B cells require antigen internalisation in order to 
become activated and develop an efficient humoral response, as well as to 
prevent excessive BCR signalling. It is known that in vivo the primary source of 
antigen is tethered to APCs, and this presentation allows context-dependent 
antigen recognition by B cells, which augments and fine-tunes the B cell 
response. It is also known that this internalisation occurs in an affinity-dependent 
manner, which allows B cells to selectively expand high affinity B cell clones for 
the production of specific antibodies.  
 
However, the mechanisms of B cell antigen extraction from APCs are still 
unknown. Studies using soluble antigen have identified specific components and 
pathways that are involved in BCR-antigen internalisation from solution, such as 
clathrin-mediated endocytosis, the actin cytoskeleton, lipid raft scaffolds and BCR 
signalling molecules. However, to date, there has not been a technique available 
to study the cellular and molecular mechanisms of BCR-antigen internalisation 
from an APC. 
 
To address this question, we aimed to design and develop an antigen-presenting 
substrate from which B cells can internalise antigen, and using this substrate, we 
hoped to identify novel components and mechanisms involved in BCR-antigen 
internalisation.  
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Chapter 2 Materials and Methods 
 
2.1 Mice 
 
C57Bl/6 mice from an internal colony (called Bl6 throughout the thesis) were 
used for all experiments and as wild-type controls unless otherwise stated. B1-
8fl/fl mice (a gift from K. Rajewsky (Sonoda et al., 1997)) were crossed with Igκ-
deficient Igκ-Ctm1Cgn/tm1Cgn mice (a gift from J. Langhorne) to produce the B1-8fl/fl 
Igκ-Ctm1Cgn/tm1Cgn strain (called B1-8 throughout the thesis) and the strain was 
backcrossed onto C57Bl/6 background. The majority of B cells in these mice are 
specific for the nitrophenyl hapten (NP or NIP). MyH9fl/fl mice (purchased from 
Mutant Mouse Regional Resource Centers (Jacobelli et al., 2010)) were crossed 
with Mb1-Cre mice (a gift from V. Tybulewicz (Hobeika et al., 2006)) and the 
strain was backcrossed onto C57Bl/6 background (called Cre+MyH9fl/fl throughout 
the thesis). These mice express Cre recombinase at the point of Igα expression 
in Pro B cells. Genotypes were confirmed using PCR analysis of DNA from ear 
snips. Mice were bred and treated in accordance with the guidelines set by the 
UK Home Office and UK NIMR Ethical Review Panel.  
 
2.2 B cell purification and cell culture 
 
Naïve B cells were obtained from splenocytes following red blood cell lysis (ACK 
buffer, Gibco) for all experiments except siRNA-mediated knockdown for which, a 
ficoll density gradient (GE Healthcare) was used. Naïve B cells were then 
negatively selected for using anti-CD43 microbeads on an autoMACs Pro 
separator (Miltenyi Biotec). Primary B cells and the Ramos human lymphoma cell 
line were cultured in RPMI 1640 media (Sigma) supplemented with 10% foetal 
bovine serum (FBS, Biosera), 1% MEM Non-Essential Amino Acids (Gibco), 2 
mM L-glutamine (PAA Laboratories), 50 µM 2-mercaptoethanol (Gibco), 100 
U/ml Penicillin and 100 µg/ml Streptomycin (Gibco). Adherent HEK293A, 
HEK293FT (both from Invitrogen), PLAT-E cells (a gift from V. Tybulewicz (Morita 
et al., 2000)) and bone marrow derived DCs were cultured in DMEM media 
(Gibco) supplemented with 10% FBS, 1% MEM Non-Essential Amino Acids, and 
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6 mM L-glutamine. 10 µg/ml blasticidin and 1 µg/ml puromycin (both InvivoGen) 
were added to PLAT-E media, 0.5 mg/ml Geneticin (Gibco) was added to 
HEK293FT media, and DCs differentiated from bone marrow cells using Flt3 
ligand (a gift from G. Stockinger) for 7 days, were matured using 1 µg/ml LPS 
(Sigma) for 24 hours. Suspension HEK293A cells were maintained at 5 x 105 
cells/ml, agitated at 120 rpm in Pro293S-CDM media (Lonza) supplemented with 
1.5% FBS and 2 mM L-Glutamine. All cells were cultured in incubators humidified 
with 5% CO2 at 37°C. 
 
2.3 Antigens 
 
BCR-specific antigen Cellular target Source 
Goat F(ab’)2 α-mouse Igκ Bl6 B cells 
Southern 
biotec 
Goat F(ab’)2 α-human IgM (µ chain specific) Ramos cells 
Southern 
Biotec 
NP (4-Hydroxy-3-nitrophenylacetic acid active 
ester)- or NIP (4-Hydroxy-3-iodo-5-
nitrophenylacetic active ester)- Osu 
B1-8 B cells Biosearch 
 
Unless otherwise stated αIgκ and αIgM antigens were labelled with Cy5 or Cy3 
using the Monoreactive dye kit (GE Healthcare) and biotinylated using EZ-link 
sulfo-NHS-LC-LC-Biotin (Thermo scientific).  
 
To generate NIP-Qdot antigens, fluorescent Quantum dots (Qdot, Invitrogen) 
were haptenated with NIP-Osu in dimethylformamide (Sigma) for 3 hours and 
biotinylated. αIgM-Qdots were produced by mixing Qdots conjugated to 
streptavidin 1:1 with biotinylated αIgM. 
 
NP or NIP antigens were produced from the haptenation of AlexaFluor647-
labelled goat F(ab’)2 (Jackson Immunoresearch) with NP- or NIP-Osu and 
biotinylated. To load cognate immune complexes onto DCs for recognition by B1-
8 B cells, NP/NIP antigen was mixed 1:1 with anti-biotin IgG1 antibodies (Sigma) 
for 30 minutes on ice. For AFM experiments, DCs were loaded with immune-
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complexes consisting of αNP antibodies (Serotec) and NIP antigens for 1 hour 
on ice.  
 
For 3D localisation of antigen particles, biotinylated-αIgκ was loaded onto PMS 
and then a small number of antigen molecules were labelled with a low 
concentration of streptavidin-conjugated Qdots.  
 
2.4 Antibodies 
 
Antibody Clone Source Final concentration 
α-mouse CD19 FITC 1D3 BD biosciences 1 µg/ml 
α-human GAPDH-
Alexa647 14C10 Cell Signaling 1:500 dilution 
α-mouse CD45R/B220 RA3-6B2 BD biosciences 1 µg/ml 
α- clathrin heavy chain 23 BD Transduction Laboratories 0.25 µg/ml 
α-Dynamin2 Polyclonal Abcam 1 µg/ml 
α-β-actin AC-74 Sigma 1:5000 dilution 
α-AP2 µ1 EP2695Y Epitomics 1:1000 dilution 
α-mouse IgM µ chain 
specific-FITC 
Catalog number: 
115-097-020 
Jackson 
Immunoresearch 5 µg/ml 
α-mouse CD93 
(AA4.1)-APC AA4.1 eBioscience 2 µg/ml 
α-mouse CD23-PE B3B4 eBioscience 5 µg/ml 
α-mouse/human 
CD45R/B220 PerCP-
Cy5.5 
RA3-6B2 Biolegend 1 µg/ml 
α-mouse CD8a-brilliant 
violet 570 53-6.7 Biolegend 0.5 µg/ml 
α-mouse CD4-efluor 
450 RM4-5 eBioscience 1µg/ml 
α-mouse CD19-APC 6D5 Biolegend 2 µg/ml 
α-mouse CD2 (LFA-2)-
PE RM2-5 BD Biosciences 2.5 µg/ml 
α-mouse IgD efluor 450 11-26 eBioscience 1 µg/ml 
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α-mouse IgD-PE 11-26 eBioscience 0.5 µg/ml 
α-mouse TCR-β-APC H57-597 eBioscience 1 µg/ml 
α-mouse CD5 (Ly-1)-
PE 53-7.3 eBioscience 2 µg/ml 
α-mouse CD23-APC B3B4 Invitrogen 1:100 dilution 
α-human/mouse 
CD45/R (B220)-efluor 
450 
RA3-6B2 eBioscience 1 µg/ml 
α-mouse/human 
CD45R (B220)-PE RA3-6B2 ebioscience 1 µg/ml 
 
2.5 Inhibitors 
 
Inhibitors were incubated with B cells in Hank’s buffered saline solution (HBSS) 
supplemented with 0.01% bovine serum albumin (BSA, Sigma). Dynasore was 
incubated with HBSS containing no BSA. All inhibitors were preincubated with B 
cells for 15 minutes at 37°C before addition to antigen-loaded PMS or soluble 
antigen. Solvent in the appropriate buffer was used as control. 
 
Inhibitor Target Source Final concentration 
PP2 Lyn Invitrogen 20 µM 
LFM-A13 Btk Caymann Chemical 50 µM 
Bisindolylmaleimide PKC Caymann Chemical 20 µM 
PD184352 Erk1/2 Selleckchem 2 µM 
SMIFH2 Formin Sigma 10 µM 
NSC-23766 Rac1 Biovision 100 µM 
Dynasore Dynamin2 T Kirchhausen 80 µM 
Blebbistatin Myosin IIA Caymann Chemical 50 µM 
Y-27632 Rock1 Sigma 50 µM 
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2.6 Planar lipid bilayers (PLB) 
 
DOPS (1,2-Dioleoyl-sn-Glycero-3-[Phospho-L-Serine] (Sodium Salt)) or DOPE-
biotin (1,2-Dioleoyl-sn-Glycero-3-phosphoethanolamine-N-(Cap Biotinyl) (Sodium 
Salt)), were mixed at a molar ratio of 1:10 with DOPC lipid (1,2-dihexanoyl-sn-
glycero-3-phosphocholine) (All from Avanti) in choloform. The lipids were dried 
overnight using argon and resuspended in degassed phosphate buffered saline 
(PBS). The lipids were then sonicated to produce unilamellar vesicles, clarified by 
ultracentrifugation at 36 000 rpm for 16 hours, and prepared in a 0.1 mM lipid 
solution in PBS. Glass coverslips were cleaned in sulfuric acid and hydrogen 
peroxide at a ratio of 3:1 and attached to Labtek imaging chambers (Nunc). Lipid 
bilayers were formed by fusing the unilaminar vesicles onto the clean coverslips.  
 
For PLB in Figure 6, PLB formed from DOPE-biotin and DOPC were incubated 
with 5 µg/ml streptavidin (Southern Biotec) in PBS, washed, and incubated with 
NIP-Qdot antigens.  
 
For PLB in all subsequent experiments, PLB from DOPS and DOPC were 
incubated with 24 nM biotinylated annexin V (BioVision) in HBSS. After washing, 
PLB were incubated with 5 µg/ml streptavidin, washed again, and incubated with 
indicated antigens. When not explicitly stated, PLB were loaded with antigens at 
1 µg/ml, resulting typically in 50 antigen molecules per µm2. In some cases, the 
concentration of antigen was titrated to achieve the density specified in the 
experiments.  The calculation of antigen density on the substrates was performed 
as previously described (Tolar et al., 2009b). Briefly, antigen was diluted to a 
concentration that allowed resolution of single antigen molecules. The average 
fluorescence intensity of the single antigen molecules was used to convert 
fluorescence intensity of experimental antigen concentrations to number of 
antigen molecules per µm2. 
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2.7 Plasma membrane sheets (PMS) 
 
Suspension HEK293A cells were seeded onto poly-L-lysine (Sigma)-coated 
Labtek imaging chambers (Nunc) and cultured overnight to 100% confluency. 
Cells were then washed in PBS and sonicated with a probe sonicator placed 5 
mm above the cells for 20 seconds at room temperature. This shears off the 
cells, leaving the ventral plasma membrane attached to the coverslip with its 
cytoplasmic side exposed. PMS were blocked with PBS supplemented with 1% 
BSA and then incubated in HBSS 0.1% BSA with 24 nM biotinylated annexin V. 
After washing, PMS were incubated with 5 µg/ml streptavidin, washed again, and 
incubated with indicated antigens as on the PLB.  
 
2.8 Plasma membrane planar lipid bilayers (PMPLB) – Wing-
Liu Lee 
 
Suspension HEK293A cells were lysed in 5 mM NaH2PO4/NaHPO4, pH 8 at 10 x 
106 cells/ ml for 30 minutes on ice, and then homogenised using Dounce tissue-
grinder pestle (Sigma). Nuclei were removed by centrifugation at 500 x g at 4°C 
for 10 minutes and plasma membranes were isolated by centrifugation at 20 000 
x g at 4°C for 30 minutes. The membrane pellet was resuspended in a buffer 
containing 500 µM NaH2PO4/NaHPO4, 100 µM MgSO4, pH 8, on ice for 1 hour. 
Membrane vesicles were then purified by centrifugation at 100 000 x g at 4°C.  
The vesicle pellet was resuspended in the same buffer and used immediately. 
PMPLB were formed by fusing the vesicles onto glass coverslips. Antigen was 
attached via biotinylated annexin V and streptavidin and its density was 
quantified as on the PLB and PMS. 
 
2.9 Imaging 
 
All microscopy analysis and live-cell imaging was carried out on an Olympus 
IX81 microscope, with an Andor iXon EMCCD Camera and 100x objective 
(Olympus).  Live-cell imaging was done at 37°C on a heated stage with an 
objective heater.   
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TIRF or epifluorescence timelapse images were acquired with time resolution of 
2-5 seconds for 20 minutes, and corrected for photo-bleaching. The TIRF angle 
was setup as shallow as possible to extend the depth of field further away from 
the coverslip. All images were aligned, background-subtracted and corrected for 
spectral bleedthrough and photobleaching. Images were analysed using ImageJ 
and Matlab (Mathworks). All Matlab algorithms were written by Pavel Tolar. 
 
Reconstructed images showing antigen internalisation from PMS, PLB and DCs 
were generated from z-stacks by first deconvoluting the stacks, and then using 
maximal projection of the middle of the cell along the y axis (PLB and PMS) or z 
axis (DCs). 
 
2.10 Atomic force microscopy (AFM) force spectroscopy – 
Pavel Tolar 
 
AFM was performed using a setup integrating AFM and optical imaging (JPK 
instruments). To carry out force spectroscopy with PMS, PLB, PMPLB and DCs, 
gold-coated Biolever cantilevers (nominal spring constant 6 mN/m, Olympus) 
were exposed to UV light for 30 minutes and then conjugated to DOTP (Pierce)-
activated streptavidin. The cantilevers were then washed and used immediately. 
Spring constant was measured for each tip using the JPK software and varied 
between 5.2 and 6.0 mN/m. PMS, PLB, PMPLB and DCs, were loaded with 
antigens, washed, and attached to poly-L-lysine coated coverslips. AFM force 
spectroscopy was carried out on PMS, PLB or PM-PLB visualised using DiI or 
DiD (Invitrogen), and on the dorsal surfaces of the DCs’ lamellopodia, visualised 
by brightfield imaging. Negligible binding was observed in samples lacking the 
biotinylated annexin V or antigen. Data were processed using the JPK analysis 
software.  
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2.11 Internalisation assays 
 
2.11.1 Soluble antigen internalisation using flow cytometry 
Internalisation of soluble antigens was measured using flow cytometry. Cells 
were incubated with biotinylated antigens for 30 minutes on ice, washed, and 
stimulated to internalise for indicated times at 37°C. Control cells were kept on 
ice. Then, cells were fixed with 2% paraformaldehyde (PFA, Alfa Aesar) and 
stained with 1 µg/ml of fluorescently labelled streptavidin (Jackson 
Immunoresearch) to visualise any antigen remaining on the cell surface. Antigen 
internalisation was calculated by subtracting the streptavidin fluorescence of the 
heated sample from the cold sample and dividing by the fluorescence of the cold 
sample. Data was analysed using FlowJo. 
 
2.11.2 Soluble antigen internalisation using microscopy 
To quantify internalisation of soluble NP/NIP antigens, B1-8 B cells were 
attached to poly-L-lysine-coated coverslips, incubated with NP/NIP antigens for 
20 minutes, fixed with 2% PFA and stained with 1 µg/ml Cy3-labelled streptavidin 
(Jackson Immunoreserach). To determine the intensity of the internalised antigen 
in each cell, background from regions outside the cells was subtracted. Z-stack 
images of antigen and streptavidin on cells were processed through a 3D 
bandpass filter and thresholded to create 3D masks. The antigen mask was 
applied to the original antigen stack. Next, the streptavidin mask was used to 
exclude antigen present on the cell surface and therefore not internalised. The 
resulting antigen fluorescence was integrated. The percentage of internalisation 
was expressed as the intensity of internalised antigen minus the antigen 
colocalised with streptavidin divided by total antigen intensity. Data was analysed 
using Matlab. 
 
2.11.3 Membrane-bound antigen internalisation 
Internalisation from PMS, PMPLB and PLB was quantified from z-stack images, 
similarly as for the NP/NIP soluble antigens, but integrating antigen fluorescence 
only from image planes above the substrate. Specifically, background was 
subtracted using regions of interest outside of presenting membranes. Z-stack 
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images of antigen were processed through a 3D bandpass filter and thresholded 
to create a 3D mask. The antigen mask was applied to the original unfiltered 
antigen stack to include endosomal antigen and exclude scattered fluorescence 
background. Internalised antigen fluorescence was then calculated by integrating 
antigen fluorescence in the masked antigen images in stacks above the 
substrate. In experiments with primary cells, we found that all antigen above the 
substrate was inaccessible to cell-impermeable secondary 1 µg/ml fluorescently 
labelled streptavidin staining and was therefore considered internalised. In 
experiments with Ramos B cells, we found that some antigen above the 
substrate was accessible to this staining. Therefore, secondary streptavidin 
staining was used to exclude the streptavidin-colocalised antigen from the 
analysis as described for soluble antigens. The percentage of internalisation was 
expressed as the intensity of internalised antigen divided by total antigen 
intensity, which included the internalised antigen and the antigen left on the 
substrate underneath the cell. The percentage of internalised antigen colocalised 
with DiI-stained lipid, was expressed as the intensity of internalised antigen, 
minus antigen not colocalised with DiI, divided by total antigen intensity. Data 
was analysed using Matlab. 
 
2.12 Fluorescence recovery after photobleaching (FRAP) 
 
FRAP imaging was performed using TIRF microscopy at 37°C. Substrates were 
labelled with DiI or loaded with antigen, imaged for 10 seconds, and then a 
circular region of 13 µm in diameter was bleached at maximum laser power for 1 
minute using the field diaphragm. Substrates were then imaged every 10 
seconds for an additional 10 minutes. Fluorescence recovery was analysed using 
ImageJ by measuring fluorescently-labelled antigen or DiI intensity in the FRAP 
region throughout the experiment. The intensity in the FRAP region was 
normalised to fluorescence in a non-bleached control region.  	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2.13 3D particle localisation – Pavel Tolar 
 
DiI-labelled PMS were loaded with Qdot-antigen. Imaging was performed in 
epifluorescence mode. 3D localisation of the Qdots was performed using a 
cylindrical lens (f = 1 m) inserted into the infinity space of the emission path 
(Huang et al., 2008). Gaussian fitting was used to extract the elipticity of the 
fluorescent spots. To convert the data to vertical distances, we acquired 
calibration images of Qdots attached to coverslips, while stepping up the 
microscope z-stage in 10 nm increments. Positional accuracy was estimated 
from timelapse images of stationary Qdots on coverslips and was ~40 nm. 
Vertical position of the Qdots in B cell synapses were expressed as their vertical 
distance from the mean position of Qdots present on the coverslip outside of 
synapses.  
 
2.14 Analysis of membrane invaginations 
 
Membrane invaginations were detected by staining the lipids in the PMS with DiI 
or DiD. The invaginations were equally detectable in epifluorescence illumination 
and in TIRF. For 3D particle localisation, the membrane dyes were excited in 
epifluorescence mode. For timelapse TIRF imaging, we used p-polarised laser, 
which produces evanescent field that is mostly vertically polarised and therefore 
preferentially excites DiI dyes in vertically oriented membranes (Sund et al., 
1999). 
 
Membrane invaginations were tracked in space and time from timelapse images 
of DiI or DiD stained PMS using previously developed tracking algorithms (Tolar 
et al., 2009b). Briefly, image sequences were aligned and normalised to the 
image of the PMS prior to cell spreading, and then processed using a bandpass 
filter. Fluorescent spots were tracked and their lifetime was calculated from the 
length of the tracks using Matlab. 
 
Intensity of antigen associated with the invaginations was calculated as the mean 
intensity in 5 by 5 pixel regions centred on the track coordinates, including 1 
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frame before the start and 1 frame after the end of the track. Antigen intensities 
were normalised to the average antigen intensity on the PMS before cell 
spreading. 
 
2.15 Protein knock-down using siRNA 
 
2 x 106 Ramos cells, or 3 x 106 primary B cells stimulated with 1 µg/ml of CpG 
(Sigma) for 24 hours, were nucleofected (Amaxa Nucleofector II) with 3 µM 
siRNA oligonucleotides (oligos, Ambion) using the Amaxa Mouse B Cell 
Nucleofector Kit or the Amaxa Cell Line Nucleofector Kit V (Lonza), respectively. 
Following nucleofection primary B cells were cultured with 200 ng/ml BAFF 
(PeproTech). Efficiency of knock-down was assessed 96 hours after 
nucleofection by western blot or flow cytometry.  
 
siRNA target siRNA oligo ID Catalog number 
Negative control No.1 - AM4635 
GAPDH - 4404025 
CD19 S63587 4390815 
Clathrin heavy chain S475 4390825 
AP2M1 S3114 4392421 
Dynamin2 S4212 4390825 
 
2.16 Western blot 
 
Ramos or primary B cells were lysed with RIPA buffer containing 1% NP-40 
(Sigma), 0.5% sodium deoxycholate (Sigma), 0.1% SDS (Sigma), protease 
inhibitor cocktail diluted 1:100 (Sigma) for 20 min on ice. Samples were then 
spun at 13 000 rpm 4°C, and proteins were separated using 10% SDS-PAGE 
(Invitrogen) in reducing conditions. Proteins were transferred to nitrocellulose 
membranes (Millipore), blocked in 5% milk in Tris Buffered Saline with 0.1% 
Tween20, and probed in the same buffer with primary antibodies against proteins 
of interest, followed by secondary antibodies conjugated to hydrogen peroxidase.  
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2.17 Lentiviral production and infection 
 
Recombinant lentiviruses were produced by lipofectamine 2000 (Invitrogen)-
mediated co-transfection of HEK293FT cells with the VSVg and δ8.9 helper 
plasmids, together with the TRC RNAi Consortium’s shRNA-containing pLKO.1 
plasmids (Sigma). Empty pLKO.1 was used as control. Lentivirus-containing 
media were harvested 72 hours following transfection and centrifuged with 
Ramos cells in the presence of 8 µg/ml polybrene (Sigma) for 90 minutes at 1350 
x g. 24 hours after spinfection, infected cells were selected using 3 µg/ml 
puromycin. 
 
shRNA Clones (Sigma) 
Target Clones 
Dynmain2 TRCN0000006649 
AP2M1 
TRCN0000060238 
TRCN0000060239 
TRCN0000060241 
TRCN0000060242 
RHOA 
TRCN0000047710 
TRCN0000047708 
TRCN0000047711 
TRCN0000047712 
ROCK1 
TRCN0000002159 
TRCN0000121092 
TRCN0000121093 
TRCN0000121094 
HIP1R 
TRCN0000117222 
TRCN0000117223 
TRCN0000117225 
TRCN0000117226 
ARH-GAP4 
TRCN0000047189 
TRCN0000047190 
TRCN0000047191 
TRCN0000047192 
ARH-GAP15 
TRCN0000047253 
TRCN0000047254 
TRCN0000047255 
TRCN0000047256 
ARH-GAP17 
TRCN0000047448 
TRCN0000047450 
TRCN0000047451 
TRCN0000047452 
ARH-GAP26 
TRCN0000029754 
TRCN0000029755 
TRCN0000029756 
TRCN0000029758 
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ARH-GAP27 
TRCN0000048354 
TRCN0000048355 
TRCN0000048356 
TRCN0000048357 
ARH-GAP30 
TRCN0000149213 
TRCN0000179792 
TRCN0000183676 
TRCN0000183499 
ARH-GEF1 
TRCN0000033564 
TRCN0000033566 
TRCN0000033567 
TRCN0000033568 
ARH-GEF2 
TRCN0000003173 
TRCN0000003174 
TRCN0000003176 
TRCN0000010764 
ARH-GEF6 
TRCN0000007400 
TRCN0000007401 
TRCN0000007403 
TRCN0000007404 
ARH-GEF18 
TRCN0000047533 
TRCN0000047535 
TRCN0000047536 
TRCN0000047537 
MYL12B 
TRCN0000053654 
TRCN0000053655 
TRCN0000053656 
TRCN0000053657 
MYL6 
TRCN0000054138 
TRCN0000054139 
TRCN0000054140 
TRCN0000054142 
MYH9 
TRCN0000029465 
TRCN0000029466 
TRCN0000029467 
TRCN0000029468 
MYO1E 
TRCN0000152890 
TRCN0000150353 
TRCN0000151296 
TRCN0000152421 
MYO1C 
TRCN0000122924 
TRCN0000122926 
TRCN0000122927 
TRCN0000122928 
 
2.18 Retroviral production and infection 
 
Retrovirus was produced by lipofectamine 2000-mediated transfection of PLAT-E 
cells (Morita et al., 2000) with pMSCV containing one of the following constructs: 
clathrin light chain-GFP (Ehrlich et al., 2004), LifeAct (Riedl et al., 2008) (a gift 
from J. Burkhardt), or myosin IIA regulatory light chain (RLC) 12B (MYL12B)-
 58 
GFP (MYL12B was amplified and inserted into pMSCV with GFP, in our lab, by 
Bhakti Mistry). Primary Bl6 B cells, pre-stimulated with 1 µg/ml CpG (Sigma) for 
24 hours, were spinfected with retrovirus-containing supernatants in the presence 
of 20 µg/ml polybrene for 90 minutes at 1350 x g. 24-48 hours after spinfection, 
infected cells were added to antigen-loaded PMS and imaged. 
 
2.19 Analysis of clathrin light chain-GFP, myosin IIA RLC-GFP, 
and LifeAct activity 
 
The intensity of myosin IIA RLC-GFP or LifeAct associated with the invaginations 
was calculated as the mean intensity in 5 by 5 pixel regions centred on the track 
coordinates, including 3 frames before the start and 1 to 2 frames after the end of 
the track. Myosin IIA RLC-GFP and LifeAct intensities were normalised to the 
average intensity in the synapse in the same frame. 
 
To calculate the colocalisation of invaginations with CCSs, the positions of CCSs 
were tracked and colocalisation for each time point in each invagination lifetime 
was considered positive if there was a CCS within 2 pixels of the invagination 
coordinates. Control colocalisation in each cell was performed using CCSs 
shifted by 5 pixels in a random direction, maintaining boundary conditions within 
in the cell. 
 
2.20 B cell phenotyping of Cre+MyH9fl/fl mice – in collaboration 
with Harold Hartweger 
 
B cells were flushed from the femur and tibia of rear left leg using 10 ml of DMEM 
and 2% FBS. B cells were removed from the peritoneal cavity by injecting 5 ml of 
PMS supplemented with 5 mM ethylenediaminetetraacetic acid, massaging 
the abdomen, and removing the fluid. B cells from the spleen and lymph 
nodes were mashed through a 70 µm strainer. All cells were washed in 
DMEM 2% FBS and then red blood cells were lysed using ACK buffer. The 
remaining cells were washed again, and stained for the cell surface 
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markers described in Chapter 5 Table 1 for 20 minutes on ice in PBS. 
Absolute cell numbers were ascertained using FlowJo. Alive cells were 
identified as negative for the Live/Dead stain (Invitrogen). 
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Chapter 3 Plasma membrane sheets are a new 
artificial substrate that can mimic antigen-presenting 
cells when studying BCR-antigen internalisation 
 
3.1 Introduction 
 
B cells are exposed to antigen primarily in the secondary lymphoid organs. B 
cells can respond to antigen in solution following antigen filtration into the B cell 
follicles (Pape et al., 2007; Roozendaal et al., 2009), but the majority of antigen 
encountered by B cells in vivo will be retained on the surface of an APC (Batista 
and Harwood, 2009; Cyster, 2010).  
 
Intravital imaging has captured the interaction of B cells with antigen-loaded 
APCs in the lymph node throughout the immune response (Phan et al., 2007; Qi 
et al., 2006; Schwickert et al., 2007; Suzuki et al., 2009) and both in vivo and in 
vitro studies have confirmed that antigen acquisition from these APCs is a 
prerequisite to B cell activation, differentiation and antibody production (Batista et 
al., 2001; Carrasco and Batista, 2007; Chappell et al., 2012; Junt et al., 2007; 
Moseman et al., 2012; Phan et al., 2007; Qi et al., 2006; Schwickert et al., 2007; 
Suzuki et al., 2009; Wang et al., 2011).  
 
To delineate the molecular mechanisms involved in B cell recognition of 
membrane-bound antigen, PLB have been used in vitro as a surrogate for APCs. 
Live-cell TIRF images of B cells interacting with antigen-loaded PLB has revealed 
that B cells initially spread over the antigen-presenting surface collecting BCR-
antigen microclusters, and then contract to bring them into the centre of the 
synapse (Depoil et al., 2007; Fleire et al., 2006). This process has been shown to 
be dependent on the structure of the BCR (Tolar et al., 2009b), BCR and CD19 
signalling (Depoil et al., 2007; Schnyder et al., 2011; Weber et al., 2008), the 
actin cytoskeleton (Liu et al., 2012; Mattila et al., 2013; Treanor et al., 2011), and 
also on the affinity, multivalency, and concentration of the antigen (Fleire et al., 
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2006; Tolar et al., 2009b). However the mechanisms and components required 
for the subsequent antigen acquisition and internalisation are still unknown.  
 
Here we aimed to develop an antigen-presenting substrate, which can support B 
cell internalisation of membrane-bound antigen in vitro. We hoped that 
visualisation of this process using TIRF microscopy would allow us to investigate 
the dynamics of BCR-antigen internalisation, and support the use of a 
membrane-surrogate in future investigations into the molecular components 
governing this process. 
 
3.2 Results 
 
3.2.1 B cells are unable to internalise antigen tethered to planar lipid 
bilayers 
To visualise internalisation of membrane-bound antigen by B cells, we initially 
used PLB as a surrogate for APCs. PLB were formed following the fusion of 
unilamellar vesicles on glass coverslips. We attached NIP-Qdot antigen to biotin-
containing lipids within the PLB using a streptavidin linker (Figure 6A). To the 
antigen-loaded PLB we then added primary splenic B1-8 B cells that express a 
BCR specific for the NIP hapten (Sonoda et al., 1997). Live cell imaging using 
TIRF microscopy showed B1-8 B cell spreading over the antigen-loaded PLB and 
the production of antigen microclusters, which was followed by contraction of the 
B1-8 B cells pulling the antigen into the centre of the synapse (Figure 6B, Movie 
1).  Loss of fluorescence from the TIRF field would be indicative of internalisation, 
since movement of antigen up into the B1-8 B cell would remove it from the 
evanescent field exciting the Qdots. However, no loss of antigen fluorescence 
from the synapse was seen during the imaging, suggesting the B1-8 B cells were 
arrested at the point of synapse formation and internalisation didn’t take place. 
This was confirmed using epifluorescent z-stack images taken every 300 nm 
throughout the B1-8 B cell interacting with PLB. Side view reconstruction of these 
images showed that antigen is not extracted from the PLB by the B cell, but is 
retained in the synapse  (Figure 6C).  
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The incapability of B1-8 B cells to internalise antigen wasn’t due to the type of B 
cells chosen, or the antigen produced, as Ramos B cells were also unable to 
extract antigen from the PLB (Figure 6C), and flow cytometry showed B1-8 B 
cells were able to internalise the NIP-Qdot antigen from solution (Figure 6D).  In 
an attempt to optimise this system we increased the affinity between the BCR 
and antigen by using MuMT-MD4 B cells, which have a BCR with over 1000 
times higher affinity for HEL antigen than the B1-8 BCR has for NIP (KA ~ 5 × 
1010 M-1 versus 3 × 106 M-1) (Carrasco and Batista, 2006a; Natkanski et al., 
2013). We also decreased the strength of the interaction between the antigen 
and lipid bilayer by conjugating peptides containing a six histidine tag to the NIP-
Qdots and anchoring the Qdots to the PLB via nickel salt-containing lipid, instead 
of using biotinylated lipids and streptavidin (Reznik et al., 1998). However, in both 
circumstances the same phenotype was seen as in Figure 6B and C.  
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Figure 6: B cells cannot internalise antigen when presented on PLB 
A) Diagram of PLB. PLB were formed following the rupture of unilamellar vesicles on glass 
coverslips. NIP-Qdots were attached to biotinylated lipids using a streptavidin linker 
B) TIRF timelapse images showing microcluster and synapse formation between B1-8 B 
cells and PLB loaded with antigen (NIP-Qdot) (white). Timelapse was done at 37°C. B1-8 B cells 
were unlabelled. Brightfield image shows the position of B1-8 B cells. Elapsed time following the 
addition of B1-8 B cells to the PMS is shown in minutes and seconds. Scale bar = 5 µm 
C) Side view reconstruction from epifluorescent z-stack images showing synapse formation 
between NIP-Qdot antigen and B1-8 B cells (left) or αIgM-Qdot antigen and Ramos cells (right). B 
cells were incubated for 20 minutes at 37°C with antigen-loaded PLB and then fixed before 
images were taken. White outline shows B cell orientation. Outline was derived from brightfield 
images. Scale bar = 5 µm   
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D) Flow cytometry plot showing decreasing surface streptavidin-Cy5 fluorescence as an 
indication of antigen (NIP-Qdot) internalisation. B1-8 B cells were incubated with antigen on ice 
for 30 minutes and then the unbound antigen was washed off. B1-8 B cells were then incubated 
at 37°C for the indicated time points to stimulate antigen internalisation. Following this, B1-8 B 
cells were fixed and stained with streptavidin-Cy5 to highlight any antigen remaining on the cell 
surface 
 
3.2.2 B cells are able to internalise antigen from plasma membrane 
sheets  
To visualise internalisation of membrane-bound antigen by B cells, we developed 
a new surrogate for APCs from the plasma membranes of adherent cells. These 
plasma membrane sheets (PMS) were formed following the sonication of 
HEK293A cells, which had been cultured on glass coverslips and then sonicated 
leaving only the adherent membrane. We anchored antigen, specific for the light 
chain of the BCR from Bl6 mice (αIgκ), to phosphotidylserine in the exposed 
inner leaflet of the PMS using an annexin-biotin-streptavidin linkage (Figure 7A). 
Scanning atomic force microscopy (AFM) revealed that the PMS was suspended 
approximately 10 nm above the coverslip consistent with the presence of 
transmembrane proteins or membrane ruffling holding up the PMS (Figure 7B). 
TIRF images of Bl6 B cells interacting with the antigen-loaded PMS showed B 
cell spreading and contraction leading to synapse formation as with the PLB 
(Figure 6B, 7C and Movie 2). However, in contrast to the PLB, the fluorescent 
antigen signal rapidly disappeared from the TIRF plane indicating internalisation 
of antigen from PMS (Figure 7C, Movie 2).   
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Figure 7: Bl6 B cells can internalise antigen presented by PMS 
A) Diagram of PMS. PMS were formed following sonication of adherent HEK293A cells 
cultured on glass coverslips. Antigen (αIgκ) was attached to the exposed phosphatidylserine in 
the inner leaflet of the remaining HEK293A plasma membrane using an annexin-biotin-
streptavidin linker  
B) Scanning AFM of PMS. Left, fluorescent image of PMS. PMS lipids were labelled with the 
hydrophobic carbocyanine dye, DiI. Middle, the area shown by the yellow rectangle scanned by 
AFM. Different colour intensities indicate different heights of the PMS above the coverslip. Right, 
vertical profile of the dotted line indicated in AFM scan. Experiment done by Pavel Tolar 
C) TIRF timelapse images showing microcluster and synapse formation between Bl6 B cells 
and antigen (αIgκ)-loaded PMS. The BCRs on Bl6 B cells were stained with αIgM Fab for 5 
minutes before addition to the imaging chamber. Timelapse was done at 37°C. Disappearance of 
antigen from the TIRF view indicates internalisation. Elapsed time following the addition of Bl6 B 
cells to the imaging chamber is shown in minutes and seconds. Scale bar = 10 µm 
 
Antigen internalisation was confirmed by side view reconstructions of 
epifluorescent z-stack images taken throughout the Bl6 B cell following 
interaction with antigen-loaded PMS or PLB. These images demonstrated the 
presence of antigen inside the Bl6 B cells when incubated with PMS but not with 
PLB (Figure 8A and B). The difference in internalisation from the different 
substrates was not due to the additional components found in the PMS, as PLB 
produced from the plasma membranes of HEK293A cells (PMPLB) did not 
support internalisation either (Figure 8B).  
 
To visualise the fate of membranes in the different substrates during BCR-
antigen internalisation, we labelled the lipids in the PMS and PLB using the 
hydrophobic carbocyanine dye, DiI. This revealed that during antigen 
internalisation, Bl6 B cells also internalised portions of the antigen-presenting 
membrane (Figure 8A and C). Imaging of B1-8 B cells acquiring NIP-antigens 
along with portions of the cell membrane from matured DCs suggested this 
process is likely to also happen during antigen acquisition from APCs in vivo 
(Figure 8C and D).  
 
In addition, fluorescence recovery after photobleaching (FRAP) experiments 
confirmed there was no qualitative difference in the fluidity of the lipids or 
diffusion of the antigen in any of the substrates. The lipid was stained with DiI, 
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and was seen to be mobile in all substrates shown by the recovery of lipid 
fluorescence to the bleached spot (Figure 9A), whereas the antigen was seen to 
be immobile in all substrates (Figure 9B). The immobility of the antigen is likely 
due to the multivalent nature of the biotin-streptavidin linkage and the 
oligomerisation of annexin anchoring the antigen to the substrate.  
 
Collectively these studies support the use of PMS instead of PLB as a surrogate 
for APCs when studying BCR-antigen internalisation. We show that B cells 
internalise antigen with portions of the presenting membrane from PMS and 
APCs but not from PLB, and this difference is not due to the composition of the 
PMS or due to its fluidity. 
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Figure 8: Primary B cells internalise antigen with portions of the presenting membrane 
from PMS and DC, but not from PLB  
A) Side view reconstruction from epifluorescent images of synapses between Bl6 B cells 
and PMS or PLB loaded with antigen (αIgκ) (Ag) as shown in Figure 7A. Lipids in the different 
substrates were stained with DiI. Bl6 B cells were incubated with the indicated substrates for 20 
minutes at 37°C and then fixed before z-stack images were taken. Bl6 B cell surface was stained 
after fixing using αB220-FITC. Scale bar = 2 µm 
B) Image quantification of Bl6 B cell internalisation of antigen from PLB, PMS or PMPLB 
(means±SEM, n=23-60 cells). Membrane vesicles used to produce PMPLB were isolated and 
purified by Wing-Liu Lee 
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C) Image quantification of colocalisation of antigen with DiI-labelled lipid in primary B cells 
after internalisation from the substrates (Means±SEM, n=12-21 cells) 
D) Epifluorescent image of a B1-8 B cell interacting with a DC loaded with NIP antigen (Ag). 
The plasma membrane of the DC was labelled with DiI. B1-8 B cells were incubated with the DCs 
for 20 minutes at 37°C and then fixed before images were taken. B1-8 B cell surface was labelled 
after fixing with αB220-FITC. Scale bar = 5 µm 
 
 
 
Figure 9: PMS are similar in their fluidity compared to PLB and PMPLB as shown by 
FRAP 
A) Lipids of the substrates were stained with DiI and then bleached for 1 minute. Arrow 
shows point of bleaching. Recovery of DiI fluorescence to the bleached spot was measured for 10 
minutes at 37°C 
B) Antigen (αIgκ) was loaded onto substrates and then bleached for 1 minute. Arrow shows 
point of bleaching. Recovery of antigen fluorescence to the bleached spot was measured for 10 
minutes at 37°C 
Membrane vesicles used to produce PMPLB were isolated and purified by Wing-Liu Lee 
 
 
3.2.3 Plasma membrane sheets are similar in their viscoelastic properties 
to antigen-presenting cells 
 
Since we have shown that B cells can internalise antigen from PMS but not PLB, 
we wondered whether the 10 nm gap between the lipids of the PMS and 
coverslip allowed the substrate to be more flexible, and whether lack of this 
space, and therefore flexibility, was the reason B cells couldn’t internalise antigen 
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from PLB. To test this hypothesis we used AFM force spectroscopy. We labelled 
the cantiliever tip with streptavidin and lowered it onto the surface of the antigen-
loaded PMS, PLB, PMPLB, or live DCs, and then retracted it. During tip 
retraction, the forces between the tip and substrate were measured until the bond 
ruptured. In this setting, these measurements can indicate the elasticity and 
flexibility of the substrates. For example, the forces during tip retraction on PLB 
and PMPLB increased rapidly to 30-40 pN and produced single-step bond 
ruptures just a few nanometers from the surface of the substrate (Figure 10A left 
hand panels and B). The requirement for large forces to pull the PLB up and 
away from the coverslip, and the fact that following generation of these forces the 
PLB snapped quickly back down onto the coverslip, indicates a high level of 
stiffness. However, on both PMS and DCs, forces only increased to 20 pN and 
then plateaued with the bonds between the tip and substrate rupturing hundreds 
of nanometers away from the substrate’s surface (Figure 10A right hand panels 
and B). These force profiles show that less force is needed to pull the PMS or DC 
membrane further away from the coverslip compared with the PLB, and suggest 
PMS and DCs have a much higher level of elasticity and flexibility. Therefore 
these results show that PMS are similar in their viscoelastic properties as APCs, 
and support the hypothesis that B cells require this flexibility in order to 
internalise antigens.  
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Figure 10: PMS are flexible and similar in their viscoelastic properties to APCs 
A) AFM force retraction curves. Curves show the force generated between the streptavidin-
coated AFM tip and antigens, during tip retraction. Antigens were αIgκ for PLB, PMPLB and PMS, 
and NIP for DCs. Speed of retraction was 0.1 µm/second 
B) AFM average retraction curves. Data points show the force generated by cantilever 
retraction from the substrates and the subsequent distance the substrate was pulled up and away 
from the coverslip until bond rupture (Means±SD, n=31-109 retraction curves).  
Experiment done by Pavel Tolar. Membrane vesicles used to produce PMPLB were isolated and 
purified by Wing-Liu Lee 
 
3.2.4 B cells pull on and invaginate the presenting membrane during 
antigen internalisation 
To visualise the effect of antigen internalisation on the presenting membrane, we 
imaged the PMS labelled with DiI during B cell antigen extraction. TIRF 
timelapses of live Bl6 B cells showed that a few seconds after B cell spreading, 
numerous spots of increased DiI fluorescence appeared in the synapse. Tracking 
of these lipid spots showed they continued to appear and disappear dynamically 
during B cell interaction with the antigen-loaded PMS (Figure 11A). The majority 
of them lasted only 5 seconds, however some lasted over 30 seconds (Figure 
11B). These spots of increased DiI fluorescence happened at sites of BCR-
antigen internalisation at both the synapse level (Figure 11C and Movie 3) and at 
the level of the individual antigen microcluster (Figure 11D).  
 
To assess whether the spots of increased DiI-labelled lipid were indeed 
associated with the upward movement of antigen, we used high-resolution 3D 
colocalisation of antigen and DiI spots. In this set of experiments lipid was 
stained with DiI, and the majority of antigen had no fluorescent label apart from a 
small percentage labelled with Qdots to allow single particle imaging. Insertion of 
a cylindrical lens into the optical path of the microscope allowed us to determine 
the vertical position of the Qdot by the change in its shape. For example, when 
the antigen-Qdot was tethered to the PMS and in focus, it was round. However, 
when the antigen-Qdot moved upwards away from the PMS, i.e. during 
internalisation, the round image was distorted into an ellipse (Figure 12A). 
Through calibration using vertical steps of the microscope stage, the change in 
shape could be converted to a vertical position. We observed that the brightness 
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of the DiI spots correlated with the upward movement of antigen-Qdots (Figure 
12B). Therefore, these studies demonstrated that the increase in DiI fluorescence 
in the B cell synapse was due to the B cell pulling up and invaginating the PMS 
during antigen internalisation.  
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Figure 11: Bl6 B cells pull on and invaginate the PMS during antigen internalisation 
A) TIRF timelapse images showing dynamic changes in DiI fluorescence (firescale, top 
panels) during Bl6 B cell interaction with antigen (αIgκ, no fluorescent label)-loaded PMS. The 
BCRs on Bl6 B cells were stained with αIgM Fab (green, bottom panels) for 5 minutes before 
addition to the imaging chamber. Timelapse was done at 37°C. Far right panels show no Bl6 B 
cell interaction with the PMS when antigen is absent. Scale bar = 5 µm 
B) Proportions of DiI-labelled invaginations of different lifetimes produced during Bl6 B cell 
interaction with antigen (αIgκ, no fluorescent label)-loaded PMS. Data was derived from tracked 
invaginations in 20 minute TIRF timelapses at 37°C (mean±SEM, n=7 cells) 
C) TIRF timelapse images showing dynamic changes in DiI fluorescence (firescale, top 
panels) during Bl6 B cell interaction with antigen (αIgκ)-loaded PMS (green, bottom panels). 
Timelapse was done at 37°C. B cells were unlabelled. Scale bar = 5 µm 
D) TIRF timelapse images of a single antigen microcluster and corresponding spot of 
increased DiI fluorescence during Bl6 B cell interaction with antigen (αIgκ)-loaded PMS. 
Timelapse was done at 37°C. Scale bar = 100 nm 
 
 
 
Figure 12: Increased spots of DiI fluorescence are associated with the upward movement 
of antigen during antigen internalisation 
A) High-resolution 3D localisation of antigen-Qdots (αIgκ) in Bl6 B cell synapses. Lipids 
were labelled with DiI. Epifluorescent images were taken before (top, left) and after (top, right) Bl6 
B cell spreading. A cylindrical lense inserted into the optical path of the microscope, caused 
distortion of the Qdot image seen when moved above the PMS (round to elipse in shape) i.e. 
when it is being internalised by the Bl6 B cell. Bottom panels show the antigen-Qdots colour-
coded for their shape. Arrow shows a Qdot which has changed its shape after addition of Bl6 B 
cells  
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B) Vertical position of antigen-Qdots plotted against the colocalised DiI fluorescence 
following Bl6 B cell spreading (n=10 cells) ***,p<0.001 for Pearson correlation test.  
Experiment done by Pavel Tolar 
 
3.2.5 Antigen internalisation occurs only at sites of long-lived 
invagination formation 
Characterisation studies of individual invaginations revealed that short-lived 
invaginations colocalised with background levels of antigen and terminated 
abruptly suggesting physical rupture (Figure 13A, left hand panel). However, 
long-lived invaginations started at points of high antigen fluorescence, indicative 
of an antigen microcluster, and both fluorescent traces disappeared from the 
TIRF field together, suggesting internalisation (Figure 13A, right hand panel). By 
grouping the invaginations by their lifetimes, we saw that the level of antigen 
fluorescence at the start of the invagination, corresponded to the subsequent 
invagination lifetime. We also confirmed that there was a significant drop of 
antigen fluorescence at the end of all invaginations lasting over 20 seconds, 
which was not seen with short-lived invaginations (Figure 13B).  
 
These results show that B cells pulled on and invaginated the presenting 
membrane during BCR-antigen internalisation. The sites of invagination 
contained variable amounts of antigen, but only those with a lifetime longer than 
20 seconds ended with productive internalisation, and the lifetime of the 
invaginations, depended on prior formation of antigen microclusters.  
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Figure 13: Invaginations produced by Bl6 B cells are dynamic and have varying lifetimes. 
Long-lived invaginations begin at sites of antigen microclustering and lead to antigen 
internalisation  
A) Antigen (αIgκ) and DiI fluorescence in a single short-lived invagination (left) or a long-
lived invagination (right). Arrow indicates internalisation  
B) Antigen (αIgκ) (Ag) fluorescence associated with tracked DiI-labelled invaginations 
grouped by their lifetime. Data was derived from 20 minute TIRF timelapses of Bl6 B cells 
interacting with antigen-loaded PMS at 37°C. The associated antigen fluorescence was analysed 
5 seconds before (dotted lines), during the lifetime (solid lines), and 5 seconds after the 
disappearance of the invagination (dotted lines) (mean±SEM, n=10 cells). *, P<0.01 in paired t-
tests between the penultimate time point of the invagination, and the time point 5 seconds after 
invagination disappearance. Matlab analysis was done by Pavel Tolar 
C) DiI fluorescence in tracked invaginations of the indicated lifetimes from the same dataset 
as in B). Matlab analysis done by Pavel Tolar 
 
 76 
3.3 Discussion 
 
We initially attempted to study BCR internalisation of membrane-bound antigen 
using PLB as surrogates for APCs. Our observations of the interaction between B 
cells and antigen-loaded PLB match the synapse formation previously reported 
(Fleire et al., 2006). However, we observed that B cells were inhibited in their 
ability to internalise antigen from these synapses, therefore, we developed a new 
antigen-presenting substrate using immobilised plasma membranes from 
adherent cells.  
 
PLB are very flat surfaces (Attwood et al., 2013; Sackmann, 1996), which have 
made them ideal substrates for high-resolution TIRF microscopy of the initial 
molecular events involved in BCR recognition of membrane-bound antigen. In 
order to expand these studies we originally intended to use these same 
techniques to study the next step in the B cell activation process: BCR-antigen 
internalisation. However, the inability of B cells to internalise antigen from PLB 
was shown both by the formation of stable synapses and absence of antigen 
detected in the B cells following synapse formation.  
 
We initially thought this was because the biotin-streptavidin-biotin linkage was 
anchoring the antigen too strongly to the PLB. In an attempt to overcome this 
limitation, we then used B cells from MuMT-MD4 mice, which have a very high 
affinity for the HEL antigen, but we still did not observe any internalisation. This 
experimental set up has been used in previous studies, which reported 
successful antigen internalisation and presentation by B cells through activation 
of co-cultured cognate T cell hybridomas (Fleire et al., 2006). The internalisation 
of antigen described in these studies could be due to the release of small 
amounts of antigen from the PLB during the long incubation times with B cells 
and cognate T cells, before assessing T cell activation. If small amounts of 
antigen were released by the PLB, and internalised and presented by B cells, it is 
possible that this was enough to activate antigen-specific T cell hybridomas, 
which are very sensitive to peptide-MHC Class II molecules. This internalisation 
could also be explained by other recent studies showing that when B cells come 
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into contact with immobilised antigen, they secrete lysosomes releasing 
hydrolases and acidifying the synapse, which causes antigen liberation from the 
presenting surface and facilities internalisation (Yuseff et al., 2011). As PLB 
completely cover the surface of the coverslip with only a 1 nm space between the 
bilayer and the glass (Sackmann, 1996), we hypothesised that this surface could 
be very inflexible and so this release of lysosomes may occur as a consequence 
of B cells being unable to generate big enough forces to extract the antigen. 
Therefore, we set out to develop a new more flexible antigen-presenting surface.  
 
Here we show the development of PMS, a new APC surrogate for microscopy 
studies into B cell antigen acquisition from antigen-presenting surfaces. PMS 
have been recently used to investigate the formation of clathrin coated pits after 
reconstitution with cytoplasmic components (Wu et al., 2010). The observed 
production of endocytic vesicles in these studies indicated a level of flexibility 
within the PMS, and as predicted, following antigen tethering, B cells were able to 
internalise antigen from this substrate.   
 
We used AFM force spectroscopy to assess the differences in flexibility between 
the PLB and PMS, and compared them to the viscoelastic properties of APCs. 
These studies demonstrated B cells would need to overcome forces of 20 pN to 
extract antigens from the PMS or DCs, which supports the values required to pull 
out nanotubes from plasma membranes previously reported (Krieg et al., 2008).  
However, in order to extract antigen from PLB the B cells would need to generate 
forces over 40 pN. This supports our hypothesis that PLB are inflexible 
substrates and suggests that the antigen-presenting surface needs to have a 
certain level of flexibility to reduce the force required by B cells to facilitate BCR-
antigen internalisation.  
 
Scanning AFM revealed that PMS were suspended approximately 10 nm above 
the coverslip. This 10 nm space is consistent with the presence of 
transmembrane proteins or ruffling of the adherent cell membranes, which are 
the source of PMS, and could account for the increased flexibility seen when 
comparing PMS with PLB. This is also the only primary difference between the 
 78 
PMS and PMPLB further supporting flexibility in the antigen-presenting surface 
as an essential factor in antigen internalisation.  
 
To visualise any changes in the topology of the presenting membrane during 
BCR-antigen internalisation, we used the hydrophobic carbocyanine dye, DiI, 
which incorporates into the lipid bilayer and acts as a reporter for changes in 
membrane shape (Sund et al., 1999). TIRF studies showed B cells actively pulled 
on and invaginated the PMS during BCR-antigen internalisation. The number of 
invaginations was more frequent and dynamic compared to detectable antigen 
microclusters, with only long-lived invaginations resulting in internalisation. The 
high number of non-productive short-lived invaginations suggests a mechanism 
whereby B cells continually screen the antigen-presenting surface, and only 
when they bind to pre-formed microclusters and overcome a force of 20pN, can 
they produce a long-lived invagination and internalise the antigen. This could 
explain how B cells acquire APC membrane proteins during BCR-antigen 
internalisation in vivo (Suzuki et al., 2009). 
 
PMS do not fully resemble APCs as they lack any adhesion and co-stimulatory 
molecules found on APCs in vivo, which could further regulate BCR-antigen 
internalisation (Carrasco and Batista, 2006a; Carrasco et al., 2004; Suzuki et al., 
2009), however, they do resemble APCs in their viscoelastic properties and are 
closer in their membrane structure than the historically used PLB. In addition, the 
use of PMS has allowed us to visualise antigen internalisation previously unseen 
at the molecular level.  
 
Therefore, although, in the future it will be important to continually optimise this 
technique to more closely resemble APCs, or use APCs themselves, to confirm 
the findings shown here, the PMS can be considered a reasonable surrogate for 
APCs, and used for the identification of molecular components and mechanisms 
involved in BCR-antigen internalisation.  
 
 
 
 
 
 79 
Chapter 4 B cells use myosin IIA contractility 
combined with clathrin-mediated endocytosis to 
internalise membrane-bound antigen 
 
4.1 Introduction 
 
Antigen binding stimulates BCR-antigen internalisation from either a cap of BCR-
antigen complexes in response to soluble antigen, (Ma et al., 2001; Salisbury, 
1980) or from a synapse when encountered with an antigen tethered to an APC 
(Batista et al., 2001).  
 
The process of BCR-antigen internalisation is thought to begin with BCR-antigen 
microclustering and translocation to lipid rafts (Cheng et al., 1999; Sohn, 2006; 
Sohn et al., 2008; Tolar et al., 2005). Once associated with the lipid rafts BCRs 
are exposed to the Src family tyrosine kinase Lyn (Cheng et al., 1999; 2001) and 
a BCR signalling cascade is initiated resulting in BCR-antigen internalisation.  
 
Studies using soluble antigen to stimulate B cells have identified many BCR 
signalling molecules as regulators of antigen internalisation. These proteins 
include Lyn itself (Ma et al., 2001; Stoddart et al., 2002), the adaptor proteins 
Bam32 and WASp (Becker-Herman et al., 2011; Niiro et al., 2004), the guanine 
exchange factors Vav 1 and 3, and the GTPase Rac (Malhotra et al., 2009a; 
2009b). These signalling proteins have also been linked to the control of the actin 
cytoskeleton, therefore also strongly indicating a requirement for actin activity in 
BCR-antigen internalisation. In addition, these studies have identified clathrin as 
the primary endocytic mediator in this process (Salisbury, 1980; Stoddart et al., 
2002). However, the precise contribution clathrin, actin and BCR signalling make 
towards BCR-antigen internalisation is still being discussed.  
 
More recently, attention has been turned to mechanisms, by which B cells extract 
antigen from APCs (Batista and Harwood, 2009; Batista et al., 2001). To model 
antigen acquisition from APCs, high-resolution live-cell imaging of B cells 
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interacting with antigen-loaded PLB have been done. These studies have 
revealed some signalling molecules involved in B cell spreading and antigen 
gathering in response to membrane-bound antigen (Arana et al., 2008; Carrasco 
and Batista, 2006a; Carrasco et al., 2004; Depoil et al., 2007; Fleire et al., 2006; 
Mattila et al., 2013; Schnyder et al., 2011; Tolar et al., 2009b; Treanor et al., 
2011; Weber et al., 2008). However, as these B cells are inhibited in their ability 
to internalise antigen from the PLB (Chapter 3), it is unknown how gathering of 
antigen in the B cell-APC synapse leads to internalisation.  
 
Therefore, while these data have identified components involved in BCR-antigen 
internalisation and the mechanisms of synapse formation, it is still unknown how 
the signalling cascade initiated by BCR-antigen binding is activating and 
recruiting the endocytic mediators. We also do not know whether the mechanism 
of BCR-antigen internalisation changes depending on the context of antigen 
encounter. 
 
For this chapter our aim was to begin to delineate the mechanisms of antigen 
internalisation by using PMS as surrogates for APCs. PMS allow live-cell imaging 
of membrane-bound antigen internalisation, which has not been previously 
possible in the studies using soluble antigen or PLB. We hoped to identify novel 
components involved in BCR-antigen internalisation using a customised genetic 
screen and small-molecule inhibition, and visualise their spatial and temporal 
activity in real-time with high-resolution TIRF microscopy.  
 
4.2 Results 
 
4.2.1 SiRNA is not a reliable method of protein knockdown for the genetic 
screen 
To identify novel components involved in BCR-antigen internalisation we planned 
to set up a customised genetic screen. This screen would allow us to 
systematically test a large number of protein candidates for a role in BCR-antigen 
internalisation and could allow the unbiased identification of new signalling 
pathways involved in this process. 
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We initially attempted to set up this technique using a siRNA-mediated protein 
knockdown approach. Although B cells are thought to be highly resistant to non-
viral methods of siRNA-mediated knockdown (Goffinet and Keppler, 2006; 
Gresch, 2004), a new amaxa nucleofection technique has been recently shown 
to increase the transfection efficiency and cell viability following siRNA 
transfection, and has proved useful in studying the effect of gene knockdowns in 
T lymphocytes (Goffinet and Keppler, 2006; Gresch, 2004; Mantei et al., 2008; 
Stallwood et al., 2006).  
 
Initial attempts to optimise siRNA nucleofection in B cells were successful. 
Approximately 50% reduction of CD19 in Bl6 B cells, and GAPDH in Ramos 
cells, was seen following siRNA nucleofection of their specific, but not control, 
oligonucleotides (Figure 14A and B). We then tested this technique using 
oligonucleotides specific for clathrin, dynamin2, or AP2. These proteins are 
known to be involved in endocytosis and BCR-antigen internalisation, and 
therefore would act as positive controls in the genetic screen (Collinet et al., 
2010; Stoddart et al., 2005; Taylor et al., 2011).  However, no reduction in protein 
levels was observed (Figure 14C). Its unlikely the absence of knockdown was 
due to high stability of the proteins, as other studies reported 90% reduction of 
clathrin under a tetracycline-sensitive promoter, in the same time frame as our 
knockdown studies, in a B cell line following doxycycline treatment (Stoddart et 
al., 2005). The unsuccessful knockdown could be because these particular 
oligonucleotides were not efficiently reducing mRNA levels. However, because of 
the high rate of failure and also high levels of cell toxicity observed, we decided 
to abandon siRNA as a method of protein knockdown and use lentiviral delivery 
of shRNA instead. This process is labour intensive compared to siRNA 
nucleofection, however the resulting transduction is reported to be higher than 
nonviral methods and successful knockdown of proteins in B cells has been 
previously reported (Gresch, 2004; Pavri et al., 2010). 
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Figure 14: Nucleofection of siRNA produces a modest protein knockdown in B cells  
A) Flow cytometry plots (left) and quantification (right) showing CD19 protein levels following 
siRNA-mediated knockdown. Protein levels were assessed using αCD19-FITC 4 days following 
siRNA nucleofection. Grey = unstained, black = control siRNA, red = CD19 siRNA (mean±SEM, 
n=3 independent expeirments) *,p<0.05 in Mann-Whitney test compared to Control siRNA 
B) Same as A but with Ramos cells and siRNA-mediated knockdown of GAPDH 
C) Western blot showing protein levels 4 days after siRNA-mediated knockdown of indicated 
proteins  
 
4.2.2 Lentiviral delivery of shRNA mediates protein knockdown of 
endocytic mediators in B cells 
To produce shRNA-lentiviral particles, we transfected the pLKO.1 lentiviral 
vectors from The RNAi Consortium (Moffat et al., 2006; Root et al., 2006) which 
contain shRNA constructs specific for our proteins of interest, into HEK293FT 
 83 
cells. Viral supernatants were collected 3 days later and used to infect Ramos 
cells.  
 
To ensure infectious particles were being produced, Ramos cells were infected 
with a control lentivirus containing a GFP construct. An increase in GFP 
fluorescence provided evidence of successful viral production and infection 
(Figure 15A). To check if infection of shRNA-lentivirus could mediate protein 
knockdown, Ramos cells were infected with dynamin2 shRNA-lentivirus. 4 days 
following infection, knockdown of dynamin2 protein levels was observed in both 
Bl6 B cells and Ramos cells (Figure 15B and C). Better knockdown efficiency 
was seen in Ramos cells compared to primary Bl6 B cells. This may be due to a 
reduced susceptibility of primary B cells to lentiviral infection compared to 
retroviral infection, which has been described anecdotally (Pavri et al., 2010). For 
this reason, we chose to use Ramos cells for the continual development of the 
genetic screen.  
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Figure 15: Infection of lentivirus-containing shRNA can mediate protein knockdown in 
Ramos cells and Bl6 B cells 
A) Flow cytometry plot showing GFP fluorescence in Ramos cells 1 day following infection of 
cells with pLKO.1-GFP lentivirus (red) or uninfected controls (grey) 
B) Western blot showing dynamin2 protein levels 4 days after infection with lentivirus-
containing dynamin2-shRNA   
C) Quantification of B (mean±SEM, n=3 independent experiments) *, p<0.05, ***,p<0.001 in 
Mann-Whitney test compared to Empty pLKO.1 
 
4.2.3 Inhibition of internalisation following protein knockdown can be 
assessed by flow cytometry or microscopy 
To understand whether the dynamin2 knockdown mediated by shRNA-lentivirus 
transduction caused a decrease in BCR-antigen internalisation, we stimulated the 
infected cells to internalise soluble antigen at 37°C. Control cells were left on ice. 
The cells were then fixed and stained with fluorescent streptavidin to visualise 
any antigen remaining on the cell surface. While the streptavidin signal 
decreased after 37°C incubation of the mock-infected samples, which is 
indicative of fewer antigens on the cell surface due to internalisation, dynamin2 
knockdown prevented this decrease indicating antigen retention on the cell 
surface, and therefore a decrease in BCR-antigen internalisation (Figure 16A and 
B). This was further confirmed by microscopy, which revealed little colocalisation 
between antigen and streptavidin in mock infected samples, as the majority of the 
antigen was inside the B cell and protected from the streptavidin binding. 
However, in the dynamin2 knockdown cells, antigen was retained on the cell 
surface resulting in a high level of antigen colocalisation with streptavidin (Figure 
16C and D).  These results support both the previous studies showing reduced 
BCR-antigen internalisation following dynamin2 inhibition (Chaturvedi et al., 
2011; Malhotra et al., 2009b), as well as the use of this technique in the 
identification of proteins involved in BCR-antigen internalisation.  
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Figure 16: Soluble antigen internalisation is inhibited following dynamin2 knockdown by 
shRNA-containing lentivirus  
A) Flow cytometry plot showing streptavidin-Cy5 fluorescence as an indicator of surface 
antigen (αIgM, no fluorescent label) levels. Ramos cells were infected with lentivirus containing 
dynamin2-shRNA (right) or empty pLKO.1 controls (left). Ramos cells were incubated with 
antigen on ice for 30 min and then the unbound antigen was washed off. Ramos cells were 
incubated at 37°C for 0 minutes (black), 15 minutes (maroon), 30 minutes (red), or 60 minutes 
(pink) to stimulate antigen internalisation. Ramos cells were then fixed and stained with 
streptavidin-Cy5 to highlight any antigen remaining on the cell surface or were left unstained 
(grey). Flow cytometry plots are representative of 2 independent experiments 
B) Quantification of A (mean±SEM, n=2 independent experiments) ****, p< 0.0001 in two-
way ANOVA test between lentiviral treatments 
C) Epifluorescent images of Ramos cells following treatment as in A) for 20 minutes. Scale 
bar = 4 µm 
D) Quantification of C (mean±SEM, n=4 fields of view per sample, approximately 20 cells for 
each lentiviral treatment) ***,p<0.001 in Mann-Whitney test compared to Empty pLKO.1 
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4.2.4 BCR-antigen internalisation is reduced in Ramos cells following 
shRNA mediated knockdown of myosin IIA and clathrin 
20 genes were chosen for a pilot run of the genetic screen. The genes chosen 
included known and predicted endocytic mediators that are expressed highly in 
murine primary B cells. 4 days following lentiviral infection, Ramos cells were 
incubated with antigen-loaded PMS and the extent of internalisation was 
analysed. If 3 out of 4 clones used for each gene showed a difference in 
internalisation by 2 standard deviations from the normalised Z score, the gene 
was counted as a positive hit. Normalised z scores demonstrated that knockdown 
of dynamin2 (an enzyme required for the pinching off of clathrin-coated vesicles), 
Ap2 (AP2M1, an essential clathrin adapter protein), myosin IIA (MYH9, a motor 
protein involved in the actomyosin cytoskeleton), and Rock1 (a myosin IIA 
activator) all caused significant decreases in BCR-antigen internalisation (Figure 
17). This inhibition was validated by subsequent repetitions  (Figure 18A) 
showing that the clathrin pathway (dynamin2 and Ap2) as well as the myosin IIA 
pathway (myosin IIA and Rock1) are important in mediating membrane-bound 
antigen internalisation in Ramos cells.  
 
The ability of Ramos cells to pull on and invaginate the PMS during antigen-
internalisation was analysed by tracking changes in DiI fluorescence in DiI-
stained antigen-loaded PMS (Chapter 3).  Interestingly the number of 
invaginations decreased only if myosin IIA or Rock1 were knocked-down and 
were unaffected by Ap2 or dynamin2 knockdown (Figure 18B). These results 
indicate B cells require myosin IIA contractility to invaginate the PMS before 
internalising antigen in a clathrin-dependent manner. 
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Figure 17: A pilot customised genetic screen was used to identify components involved 
in antigen internalisation from the PMS  
Ramos cells were infected with shRNA-lentivirus and 4 days later were incubated with antigen 
(αIgM)-loaded PMS for 20 minutes at 37°C. Cells were then fixed before internalisation was 
analysed. Each gene was targeted by 4 separate shRNA sequences. Red bars indicate Z 
values 2 standard deviations or more away from the mean (n=>20 cells, n=1 experiment for 
each gene) 
 
 
 
Figure 18: Ramos cells need to invaginate the PMS using myosin IIA contraction before 
internalising the antigen in a clathrin-dependent manner  
A) Repetition of positive hits shown in Figure 17. Antigen (αIgM) internalisation from PMS by 
Ramos B cells expressing shRNA against AP2, dynamin2, Rock1, or myosin IIA. Ramos cells 
were incubated with PMS for 20 minutes at 37°C and then fixed before internalisation was 
analysed. Values shown are pooled results from all 4 shRNA clones (mean±SEM n=>60 cells 
over 3 independent experiments). f.u., fluorescent units, ****, p<0.0001 in Mann-Whitney test 
compared to Empty pLKO.1 
B) Number of tracked DiI-labelled invaginations pulled from the PMS by Ramos B cells 
expressing shRNA against AP2, dynamin2, Rock1, or myosin IIA. Tracks were taken from a 20 
minute timelapse of Ramos cells interacting with antigen (αIgM)-loaded PMS at 37°C. 
(mean±SEM n=>20 cells over 2 independent experiments). ****, p<0.0001, ***, p<0.001 in Mann-
Whitney test compared to Empty pLKO.1 
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4.2.5 BCR-antigen internalisation is reduced in Bl6 B cells following 
pharmacological inhibition of myosin IIA and clathrin 
To confirm the results of the pilot screen in Ramos cells independently, we ran 
another pilot screen using Bl6 B cells and small molecule inhibitors against 
known and possible endocytic mediators, as well as BCR signalling molecules. 
Inhibition of Rock1 as well as myosin IIA itself, supported the requirement of the 
myosin IIA pathway in BCR-antigen internalisation and PMS invagination, and 
dynamin2 inhibition supported the need for clathrin-mediated endocytosis (Figure 
19A). Lyn and formin inhibitors confirmed previous reports showing BCR 
signalling and the actin cytoskeleton are also needed in BCR-antigen 
internalisation (Brown and Song, 2001; Fleire et al., 2006; Ma et al., 2001; 
Stoddart et al., 2005), whereas PKC and Rac1 were seen to be dispensable 
(Arana et al., 2008; Weber et al., 2008). Erk1/2 signalling was also seen to be 
important in BCR-antigen internalisation, which supports recent findings 
suggesting BCR signalling continues following BCR-antigen internalisation 
(Chaturvedi et al., 2011).   
 
Comparing internalisation of soluble or membrane-bound antigen by Bl6 B cells 
supported the idea that clathrin and myosin IIA have independent roles in BCR-
antigen internalisation. Dynamin2 inhibition (mediated by dynasore) prevented 
internalisation of antigen whether in solution or tethered to the PMS (Figure 19B). 
However, it did not stop the B cell from invaginating the PMS (Figure 19C) or 
BCR signalling, as Bl6 B cells inhibited by dynasore, were able to spread over 
the PMS, form microclusters and contract bringing them into a central synapse 
(Figure 20). This suggests clathrin acts as the endoytic mediator in this process 
but is not required for BCR signalling or PMS invagination prior to internalisation.  
 
In contrast, internalisation following a reduction in the activity of the myosin IIA 
pathway (mediated by blebbistatin and Y-27632) was only decreased when the 
antigen was membrane-bound, and antigen internalisation from solution was 
unaffected (Figure 19B). These inhibited cells were also unable to invaginate the 
PMS (Figure 19C) or contract in response to membrane-bound antigen shown by 
an increase in synapse size (Figure 20). These results suggest myosin IIA is the 
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component responsible for producing the force needed for membrane 
invagination prior to membrane-bound antigen internalisation (Chapter 3), but as 
less force is required for soluble antigen internalisation, its activity is dispensable 
when antigen is in solution. 
 
 
 
 
 91 
 
Figure 19: Bl6 B cells invaginate the PMS using myosin IIA contraction before 
internalising the antigen in a clathrin-dependent manner 
A) Small molecule inhibitor screen. Relative antigen (αIgκ) internalisation from PMS 
following protein inhibition in Bl6 B cells. Bl6 B cells were pre-incubated with indicated inhibitor for 
15 minutes before addition to the PMS. Bl6 B cells were then incubated with PMS and inhibitor for 
a further 20 minutes at 37°C and fixed before internalisation was analysed. (mean±SEM, n=>30 
cells, n=1 experiment for each inhibitor). ****, p<0.0001, *, p<0.05 in Mann-Whitney test 
compared to solvent controls  
B) Comparison of antigen (αIgκ) internalisation from PMS (solid bars, left y axies) or solution 
(empty bars, right y axies) by Bl6 B cells incubated with inhibitors against dynamin2 (dynasore), 
Rock1 (Y-27632), or Myosin IIA (blebbistatin). Bl6 B cells were fixed before internalisation was 
analysed. (mean±SEM n=>60 cells over 3 independent experiments). f.u., fluorescent units, ****, 
p<0.0001 in Mann-Whitney test compared to solvent controls 
C) Number of tracked DiI-labelled invaginations from a 20 minute timelapse of Bl6 B cells 
treated with indicated inhibitors interacting with antigen (αIgκ)-loaded PMS at 37°C. (mean±SEM 
n=>20 cells over 2 independent experiments). ****, p<0.0001, ***, p<0.001 in Mann-Whitney test 
compared to solvent control 
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Figure 20: Inhibition of myosin IIA, Rock1 or dynamin2 affects the extent of Bl6 B cell 
spreading on the PMS 
A) TIRF images showing difference in synapse sizes (red) made by Bl6 B cells on antigen 
(αIgκ)-loaded PMS. B cells were unlabelled. Bl6 B cells were incubated with PMS and inhibitor for 
20 minutes at 37°C and then fixed before images were captured. Red outlines represent edges of 
B cell spreading and were derived from brightfield images 
B) Quantification of D. (mean±SEM, n=30-50 cells over 2 independent experiments) 
****,p<0.0001 in Mann-Whitney test compared to solvent control 
 
4.2.6 Clathrin is recruited to the synapse at the point of antigen 
internalisation 
To visualise clathrin, myosin IIA and actin activity during BCR-antigen 
internalisation from the PMS, we infected stimulated Bl6 B cells with retrovirus 
containing GFP-labelled clathrin light chain, GFP-labelled myosin IIA regulatory 
light chain (RLC), or the F-actin specific fluorescent probe LifeAct (Riedl et al., 
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2008), respectively. Successful infection of Bl6 B cells by retrovirus was shown 
by increased GFP fluorescence using flow cytometry compared to uninfected 
controls (Figure 21A).  
 
TIRF images of Bl6 B cells infected with clathrin light chain-GFP on antigen-
loaded PMS showed an increase in the number and brightness of clathrin-coated 
structures (CCS) in the synapse during B cell spreading and antigen-
internalisation (Figure 21B and C, Movie 4). Tracking of invaginations allowed us 
to analyse the colocalisation of invaginations with CCSs, and showed us that 
short-lived invaginations contained little clathrin, but that this colocalisation 
increased up to 20% with long-lived invaginations, peaking towards the end of 
the invagination lifetime (Figure 21D and E). Observations of clathrin and antigen 
activity in two separate long-lived invaginations revealed the sequential formation 
of antigen microclusters, invagination of the membrane, and recruitment of 
clathrin (Figure 22A and B). Although comparisons between the 2 invaginations 
revealed different temporal regulation (possibly due to differences in antigen 
microcluster size), both followed the same recruitment pattern of antigen, 
invagination, and clathrin, and in both cases simultaneous disappearance of all 
three fluorescent traces was observed indicating the point of internalisation. 
These observations support the hypothesis suggested in Chapter 3, that 
successful internalisation occurs by sustaining long-lived invaginations at sites of 
antigen microclustering. If the invagination is sustained long enough, CCSs 
assemble allowing successful internalisation. In contrast, short-lived 
invaginations terminate before clathrin is recruited and endocytosis can occur. 
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Figure 21: Retroviral infection of clathrin light chain-GFP in Bl6 B cells show clathrin 
recruitment to Bl6 B cell synapse, and colocalisation of clathrin with long-lived 
invaginations during antigen internalisation from the PMS 
A) Flow cytometry plot showing GFP fluorescence in Bl6 B cells 48 hours following retroviral 
infection of clathrin light chain-GFP (red) or uninfected controls (grey) 
B) Images from a TIRF timelapse showing clathrin recruitment to Bl6 B cell synapse with 
antigen (αIgκ)- loaded PMS. Bl6 B cells were infected with clathrin light chain-GFP retrovirus and 
imaged 48 hours later. Timelapse images were taken at 37°C. B cells were unlabelled. White 
outline represents edges of B cell spreading derived from brightfield images. Scale bars = 5 µm 
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C) Quantification of the number (red, left hand y axis) and brightness (blue, right hand y 
axis) of CCSs in Bl6 B cell synapses on antigen (αIgκ)-loaded PMS. CCSs were tracked over a 
20 minute TIRF timelapse 48 hours after Bl6 B cells were infected with clathrin light chain-GFP  
(mean±SEM, n=15-21 cells). *, p<0.05 in Mann-Whitney tests for time>1 minute against no-
antigen controls  
D) Images from a TIRF timelapse showing colocalisation of CCSs in a Bl6 B cell synapse 
with DiD-labelled invaginations on an antigen (αIgκ, no fluorescent label)- loaded PMS. Bl6 B 
cells were infected with clathrin light chain-GFP retrovirus and imaged 48 hours later. Timelapse 
images were taken at 37°C. Image shown was taken 13 minutes after Bl6 B cells were added to 
the PMS. Scale bars = 5 µm 
E) Percentage of CCS fluorescence associated with tracked DiD-labelled invaginations 
grouped by their lifetime. Data was derived from 20 minute TIRF timelapses of clathrin light chain-
GFP expressing Bl6 B cells, interacting with antigen (Igκ, no fluorescent label)-loaded PMS at 
37°C. The associated clathrin light chain-GFP fluorescence was analysed 5 seconds before 
(dotted lines), during the lifetime (solid lines), and 5 seconds after the disappearance of the 
invagination (dotted lines) (mean±SEM, n=12 cells). Black lines, colocalisation of CCSs with 
randomly scrambled controls. *, p<0.01 in Mann-Whitney tests against scrambled controls. 
Matlab analysis was done by Pavel Tolar. 
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Figure 22: Bl6 B cells internalise antigen from the PMS following the sequential 
formation of antigen microclusters, long-lived invaginations and CCSs  
A) Formation of a single antigen (αIgκ) microcluster (arrows, top panels), followed by 
invagination of DiI-labelled PMS (second row panels), and recruitment of clathrin (third row 
panels). All three fluorescent images disappear at the same time indicating internalisation. 
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Images were taken from a 20 minute TIRF timelapse of Bl6 B cell expressing clathrin-GFP on 
antigen (αIgκ)-loaded and DiI-stained PMS at 37°C. Scale bar = 100 nm 
B) Fluorescent traces of a separate antigen microcluster showing same sequential formation 
of antigen microcluster, DiI invagination, and CCS as above. Arrows show point of recruitment/ 
formation, and dotted line shows point of internalisation 
 
4.2.7 Myosin IIA is recruited to the synapse immediately before 
invagination formation 
TIRF timelapse images of myosin IIA RLC-GFP and LifeAct activity also support 
myosin IIA and actin involvement in BCR-antigen internalisation as both showed 
specific patterns of localisation in the B cell synapse (Figure 23A, 24A, Movie 5 
and Movie 6). Analysis of myosin IIA colocalisation with membrane invaginations 
revealed that myosin IIA recruitment peaked just before the onset of all 
invaginations irrelevant of their lifetime, in agreement with the idea that the force 
required for invagination formation is myosin IIA-dependent (Figure 23B and C). 
In contrast actin was recruited in a biphasic manner, firstly at the onset of the 
invagination, and then secondly at the end of the invagination if it lasted 20 
seconds or longer (Figure 24B and C). The first wave of recruitment supports the 
involvement of actomyosin cytoskeleton in invagination formation and the second 
wave supports previous studies showing actin assists in clathrin-mediated 
endocytosis when force is required to extract the cargo (Boulant et al., 2011; 
Cureton et al., 2010). 
 
Collectively these results suggest that following membrane-bound antigen 
encounter, B cells use forces generated by the actomyosin cytoskeleton to pull 
on and invaginate the presenting membrane. The invagination lifetime depends 
on the prior formation of antigen microclusters and if the invagination persists 
long enough, CCS are recruited, and antigen internalisation occurs in a clathrin- 
and actin-dependent manner.  
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Figure 23: Myosin IIA is recruited to the Bl6 B cell synapse at the onset of invagination 
formation 
A) Images from a TIRF timelapse showing myosin IIA recruitment to the Bl6 B cell synapse 
with antigen (αIgκ, no fluorescent label)- loaded DiD-stained, PMS. Bl6 B cells were infected with 
myosin IIA RLC-GFP retrovirus and imaged 48 hours later. Timelapse images were taken at 
37°C. Image shown was taken 3 minutes after Bl6 B cells were added to the PMS. Scale bars = 5 
µm 
B) Myosin IIA RLC-GFP fluorescence associated with tracked DiD-labelled invaginations 
grouped by their lifetime. Data was derived from 20 minute TIRF timelapses of myosin IIA RLC-
GFP expressing Bl6 B cells, interacting with antigen (αIgκ, no fluorescent label)-loaded PMS at 
37°C. The associated myosin IIA RLC-GFP fluorescence was analysed 15 seconds before 
(dotted lines), during the lifetime (solid lines), and 5 seconds after the disappearance of the 
invagination (dotted lines) (mean±SEM, n=15 cells). *, p<0.01 in paired t-tests between myosin 
IIA RLC-GFP fluorescence values 15 seconds and 5 seconds before invagination onset, and 
between 5 seconds before invagination onset and 5 seconds after invagination onset. Matlab 
analysis was done by Pavel Tolar 
C) Myosin IIA RLC-GFP and DiD fluorescence in a single long-lived invagination. 
Fluorescent trace shows peak of myosin IIA recruitment to the synapse just before onset of 
invagination  
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Figure 24: F-actin is recruited to the Bl6 B cells synapse in a biphasic manner 
A) Images from a TIRF timelapse showing LifeAct (a fluorescent probe which binds to F-
actin) recruitment to the Bl6 B cell synapse with antigen (αIgκ, no fluorescent label)- loaded DiD-
stained, PMS. Bl6 B cells were infected with LifeAct retrovirus and imaged 48 hours later. 
Timelapse images were taken at 37°C. Image shown was taken 5 minutes after Bl6 B cells were 
added to the PMS. Scale bars = 5 µm 
B) LifeAct fluorescence associated with tracked DiD-labelled invaginations grouped by their 
lifetime. Data was derived from 20 minute TIRF timelapses of LifeAct expressing Bl6 B cells, 
interacting with antigen (αIgκ, no fluorescent label)-loaded PMS at 37°C. The associated LifeAct 
fluorescence was analysed 15 sec before (dotted lines), during the lifetime (solid lines), and 10 
seconds after the disappearance of the invagination (dotted lines) (mean±SEM, n=13 cells). *, 
p<0.015 in paired t-tests between LifeAct fluorescence values before invagination onset and 10 
seconds prior to invagination onset (black bracket) and between values at invagination 
termination and 10 seconds after invagination termination (colour brackets). Matlab analysis was 
done by Pavel Tolar  
C) LifeAct-GFP and DiD fluorescence in a single long-lived invagination. Fluorescent trace 
shows two peaks of actin recruitment to the synapse; the first with invagination onset and the 
second as the invagination is terminated  
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4.3 Discussion 
 
Using both shRNA-mediated knockdown and protein inhibition we have been 
able to identify molecular components involved in membrane-bound antigen 
internalisation for the first time. Live cell imaging of B cells interacting with the 
PMS allowed us to visualise the temporal and spatial regulation of these 
identified proteins and therefore understand their distinct roles in BCR-antigen 
internalisation.  These molecular components were shown to be important for 
antigen internalisation in both primary mouse cells and a human cell line 
indicating conservation of this mechanism across different species.  
 
Internalisation of both soluble antigen and antigen tethered to the PMS were 
reduced following inhibition of the components of CCSs; dynamin2 and AP2 
(Figures 16, 17, 18 and 19). These results confirmed previous studies identifying 
clathrin as the main endocytic mediator in soluble antigen internalisation 
(Salisbury, 1980; Stoddart et al., 2002; 2005), and also indicated a previously 
unknown role for clathrin in membrane-bound antigen internalisation. Although 
we demonstrated clathrin was involved in both types of antigen internalisation, it 
is unlikely that both types of endocytosis occur in the same way. Recent studies 
suggest that the mode of clathrin-mediated endocytosis can alter depending on 
the force required for internalisation (Kirchhausen, 2009). For instance, 
endocytosis of small soluble cargo from plasma membranes with low surface 
tension, occurs using canonical clathrin coated pits (CCPs) (Boulant et al., 2011; 
Kirchhausen, 2009) which are restricted in their size (approximately 30-100 nm 
(Cureton et al., 2010; 2009)) and generally take approximately 30 seconds to 
form and endocytose (Kirchhausen, 2009). In contrast, endocytosis of very large 
cargo (over 120 nm) (Cureton et al., 2009; 2010) require much bigger CCSs, 
which can persist for minutes, and are dependent on force generation (Merrifield 
et al., 2002; 2005; Taylor et al., 2011). CCSs are also required to internalise 
cargo from membranes under high surface tension (Boettner et al., 2011; Boulant 
et al., 2011). This force generation is thought to be actin dependent and 
examples of interactions between clathrin and actin during endocytosis have 
been shown (Boulant et al., 2011; Calabia-Linares et al., 2011; Kirchhausen, 
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2009; Merrifield et al., 2002; 2005). Considering all studies of soluble antigen 
internalisation to date have been done using small protein antigens, together with 
the assumption that little or no force is required for internalisation from solution, it 
is likely that soluble BCR-antigen internalisation happens independently of force 
generation, and through canonical CCPs. In this case, actin polymerisation is 
needed only to overcome the tension of B cell plasma membrane and could 
explain the modest reduction in soluble antigen internalisation reported following 
actin inhibition (Stoddart et al., 2005). In contrast, since BCR-antigen 
internalisation from the PMS requires force generation to extract the antigen from 
the opposing membrane (Chapter 3), it is likely this method of clathrin-mediated 
endocytosis happens in a non-canonical way using CCSs, which is reminiscent of 
maturation and disassembly of focal adhesions (Ezratty et al., 2009; Levayer et 
al., 2011).  
 
The requirement for actin-dependent non-canonical CCS involvement in BCR-
antigen internalisation is supported by our live-cell imaging of clathrin light chain-
GFP. In these studies we observed the recruitment and development of CCSs, a 
few of which lasted 30 seconds or more, and the internalisation of antigen 
microclusters which may have been too big to fit into a CCP (Figure 16C and 
Movie 4). Independently we also noted that inhibition of some actin 
polymerisation proteins (formins) inhibited BCR internalisation of membrane-
bound antigen, and visualisation of actin through LifeAct showed the second 
wave of actin assembly (after the membrane invagination) coincided with clathrin 
recruitment (Figure 19B, 22B and 24C). However, we were not able to analyse 
internalisation from the PMS following complete inhibition of actin polymerisation 
because this treatment severely reduces the ability of B cells to spread and 
attach to the PMS.  
 
Although our studies strongly indicate clathrin is the primary endocytic mediator 
of BCR-antigen internalisation, we still do not know the mechanics behind this 
process. For instance, knockdown and inhibition of dynamin2 and AP2 
demonstrate clathrin involvement, as these are universally required for clathrin-
mediated endocytosis (Boucrot et al., 2010; McMahon and Boucrot, 2011; 
Merrifield et al., 2002), but it remains unclear whether AP2 binds directly to the 
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BCR or whether other adaptors are involved (Boucrot et al., 2010; Hou et al., 
2006; McMahon and Boucrot, 2011). These studies also do not shed light on 
whether BCR signalling recruits and initiates clathrin assembly, which has been 
seen in response to some cargo (Cureton et al., 2009), or whether BCR 
engagement of antigen merely stabilises CCSs which initiate randomly (Ehrlich et 
al., 2004). In addition, our live-cell TIRF imaging of clathrin light chain-GFP 
activity does not discriminate between endosomal clathrin close to the cell 
surface and clathrin involved in endocytosis. It has been suggested that 
endosomal clathrin in T lymphocytes has a separate role to the clathrin mediating 
endocytosis (Calabia-Linares et al., 2011) and therefore it would be important in 
the future to discriminate between endosomal and plasma membrane forms of 
clathrin in B cells to fully understand the dynamins of clathrin during BCR-antigen 
internalisation.  
 
In addition to clathrin, we also observed that myosin IIA activity was vital in BCR-
antigen internalisation from the PMS. Nonmuscle myosin IIA is a motor protein 
highly expressed in B cells and through its actin binding properties can control 
the cytoskeleton. Myosin IIA activity has been linked with a broad range of 
cellular processes such as cell migration, cytokinesis and adhesion, and in each 
of these roles myosin IIA contraction during interaction with actin provides the 
force needed for these processes to occur (Conti and Adelstein, 2008; Lecuit et 
al., 2011; Vicente-Manzanares et al., 2009). Therefore, it is likely myosin IIA 
contraction is the force generator needed for antigen extraction from the PMS. 
This idea is supported firstly by the fact that soluble antigen internalisation, which 
does not require high levels of force, is not affected by myosin IIA inhibition 
(Figure 19B), and secondly by the live-cell imaging of myosin IIA RLC-GFP in B 
cells interacting with the PMS where we observed the peak in myosin IIA 
recruitment occurring just before invagination onset. This leads us to hypothesise 
that myosin IIA organises actin to form a contractile ring at the site of force 
generation, then myosin IIA contracts the bound-actin leading to invagination of 
the membrane. Myosin IIA has also been seen to increase its contractility 
strength under increasing reverse loads (Kovács et al., 2007), which could 
explain how B cells are able to withstand the opposing tension of the PMS long 
enough for sufficient clathrin recruitment and productive antigen internalisation.  
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How myosin IIA activity and localisation are controlled at the B cell synapse is 
unknown. One possibility is that, as in the maintenance of epithelial cell junctions, 
B cell adhesion to the PMS stimulates actin adaptor protein recruitment and actin 
polymerisation, this in turn stimulates myosin IIA activity, which provides the 
required contractile force (Lecuit et al., 2011). We have also identified the 
activator of myosin IIA, Rock1 (Pellegrin and Mellor, 2007) as an important 
protein in the regulation of BCR-antigen internalisation. Rock1 controls myosin 
IIA activity by the phosphorylation of myosin IIA regulatory light chains and is 
activated by RhoA, which is stimulated following BCR binding to antigen (Dal 
Porto et al., 2004; Vicente-Manzanares et al., 2009). Reports have also 
suggested that myosin IIA can be controlled through phosphorylation of its heavy 
chain, however one of the proteins known to mediate this phosphorylation; PKC 
(Figure 19A) was seen to be dispensable for BCR-antigen internalisation in our 
studies (Vicente-Manzanares et al., 2009). Therefore, further investigations into 
other components that are able to phosphorylate the myosin IIA heavy chains will 
allow better understanding of whether this type of myosin IIA regulation plays a 
prominent role in BCR-antigen internalisation.  
 
Interestingly B cells were able to spread and form large synapses independently 
of myosin IIA activity. This supports other reports suggesting that B cell 
spreading is an actin-dependent process (Fleire et al., 2006) and suggests that 
myosin IIA contractility is required after initial synapse formation for invagination 
of BCR-antigen microclusters.  The biphasic recruitment of actin observed during 
BCR-antigen internalisation, and its ability to interact with both myosin IIA and 
clathrin pathways, indicates different roles for the cytoskeleton depending on 
which point of the internalisation process is under investigation. However as 
LifeAct binds to all filamentous actin we cannot decipher between these roles in 
these experiments.  
 
Taken together it is clear that the force generated by myosin IIA is a vital 
component involved in BCR-antigen internalisation. However, the molecular 
mechanisms controlling and regulating myosin IIA in this system will require 
further study. 
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ShRNA-mediated knockdown experiments are limited in their use, as successful 
knockdown following transduction of shRNA constructs cannot be guaranteed. In 
addition, if knockdown is achieved, another protein may compensate for the initial 
protein loss. Off targets effects are also possible, which could lead to the 
identification of false positive hits. For example, our shRNA studies did not pick 
up RhoA even though it is a well-known activator of Rock1 and therefore myosin 
IIA. Despite these limitations, continuing the shRNA screen by using 4 clones per 
gene, and by targeting many genes per pathway, should reduce the chance of 
mis-identifying protein hits.  
 
Whilst the myosin IIA, clathrin and actin pathways identified are involved in a 
large array of different cellular processes, their situation-specific function 
depends on the adaptor proteins and signalling molecules controlling them in a 
particular circumstance. Identification of these regulators by continuing the 
screen, and subsequent visualisation by using live-cell microscopy, will allow us 
to delineate the precise roles by which actin polymerisation, myosin IIA 
contraction, and clathrin recruitment can orchestrate endocytosis of membrane-
bound antigen. Ultimately we hope that continuing this genetic screen will allow 
us to gain a better understanding of how these processes are regulated and 
linked together, and what translates antigen-stimulated BCR signalling to antigen 
internalisation, so we can begin to piece together the parts of this complex 
molecular puzzle.  
 
Collectively these results support a mechanism which links contractility to 
endocytosis in BCR-antigen internalisation (Levayer et al., 2011). Here we show 
that following antigen recognition, myosin IIA is activated to pull on the BCR-
antigen microclusters causing invagination of the PMS. If the invagination is 
sustained for over 20 seconds, successful assembly of the CCS can occur and 
endocytosis of antigen follows. Interestingly, as shown in Chapter 3, the majority 
of invaginations are short-lived (approximately 5 seconds), occur at sites of 
minimal antigen clustering, and do not end with a productive internalisation. This 
suggests BCR-antigen bonds found in small microclusters (low avidity) rupture 
under the high force generated by myosin IIA before clathrin can be assembled, 
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and only microclusters with enough BCR-antigen bonds (high avidity) can 
maintain the invagination and stimulate productive internalisation.  
 
However, In vivo, B cells not only need to discriminate between antigens of 
different avidities, but also between antigens of different affinities, to ensure the 
selection of high affinity B cell clones. The size of the BCR-antigen microcluster 
has been shown to depend on the BCR affinity for the antigen (Liu et al., 2010), 
therefore, we can assume that BCR-antigen bonds of low affinities will produce 
smaller microclusters that will rupture under the myosin IIA contractility, whereas 
BCR-antigen complexes of high affinity will produce bigger microclusters that are 
able to withstand the contractile forces and become internalised. This leads us to 
hypothesise that this mechanical testing immediately before internalisation could 
provide a possible proofreading mechanism for affinity discrimination in vivo.  
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Chapter 5 Myosin IIA contractility enables B cells to 
discriminate between antigen affinities 
 
5.1 Introduction 
 
The development of an effective immune response depends on the selective 
expansion of high affinity B cell clones to produce high affinity antibodies in 
response to infection.  
 
In vitro studies have shown that B cells with high affinity BCRs are seen to have 
increased levels of signalling (Kouskoff et al., 1998), antigen accumulation (Liu et 
al., 2010), and antigen internalisation and presentation (Batista et al., 2001) 
compared to B cells with low affinity BCRs. This shows BCRs have the intrinsic 
ability to discriminate between antigen affinities. However, in vivo both high and 
low affinity BCRs can elicit comparable antibody responses, and only when 
competition between BCRs of different affinities are introduced, is affinity 
discrimination shown by a selective expansion of high affinity B cells (Schwickert 
et al., 2011; Shih et al., 2002a; 2002b).   
 
This shows that affinity discrimination in vivo also requires a competition-based B 
cell extrinsic mechanism. Studies have suggested that this results from limiting T 
cell help to B cells presenting the highest level of antigen either at the B-T cell 
boarder or within the germinal centre (Schwickert et al., 2011; Victora et al., 
2010). Therefore, taken together, these studies indicate that the increased levels 
of signalling through high affinity BCRs leads to more antigen internalisation and 
monopolisation of T cell help, demonstrating a link between affinity-dependent 
antigen internalisation and affinity discrimination.  
 
In this set of studies we investigated whether myosin IIA contraction and 
invagination of PMS during BCR internalisation of membrane-bound antigen 
shown in Chapter 3 and 4, could contribute to the affinity-dependent 
internalisation and therefore affinity discrimination shown in vivo.  We 
hypothesised that the interaction between BCR and high-affinity antigen would be 
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able to withstand the myosin IIA contractility, and internalise antigen, more 
successfully compared to low affinity antigen.  
 
5.2 Results 
 
5.2.1 B cells internalise antigen presented by plasma membrane sheets 
in an affinity-dependent manner 
To test the ability of B cells to discriminate between antigen affinities presented 
on the PMS we used B1-8 B cells which are specific for the low affinity NP, and 
the high affinity NIP, antigens. These antigens differ approximately 10 times in 
their monovalent affinity for the Fab fragment of the B1-8 BCR (Natkanski et al., 
2013). In solution, B1-8 B cells were able to internalise both antigens to a similar 
extent (Figure 25A). This could be due to the high avidity nature of NP/ NIP 
antigens complexed to a protein carrier (goat (Fab’)2), which may raise the 
immunogenicity of the antigens above the Ka ~ 1010 M-1 threshold, so the B cells 
would not be able to discriminate between them (Batista and Neuberger, 1998; 
2000). However, when they were tethered to the PMS, B1-8 B cells internalised 
significantly more of the high affinity NIP antigen compared to the low affinity NP 
(Figure 25B and C).  
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Figure 25: B1-8 B cells can discriminate between antigen affinities when presented on 
PMS 
A) Antigen (NP/NIP) internalisation from solution by Bl6 or B1-8 B cells. B cells were 
attached to the coverslip and incubated with antigen for 20 minutes at 37°C. B cells were then 
fixed and any antigen remaining on the cell surface was labelled with streptavidin-Cy3 before 
analysing the extent of internalisation (mean±SEM, n= 25-118 cells, over >2 individual 
experiments) 
B) Antigen (NP/NIP) internalisation from PMS by Bl6 or B1-8 B cells. B cells were incubated 
with antigen-loaded PMS for 20 minutes at 37°C. Cells were then fixed before analysing the 
extent of antigen internalisation (mean±SEM, n= 25-118 cells, over >2 individual experiments). *, 
p<0.001 in Mann-Whitney test between NP and NIP antigens 
C) Side view reconstruction from epifluorescent images of synapses between B1-8 B cells 
and antigen (NP/NIP)-loaded PMS. B1-8 B cells were incubated with PMS for 20 minutes at 
37°C, and then fixed before z-stack images were taken. White outline shows B1-8 B cell 
orientation. Outline was derived from brightfield images. Scale bar = 4 µm 
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5.2.2 Antigen clustering and invagination lifetime depends on antigen 
affinity 
To assess the differences in synaptic activity between the two antigens we 
tracked both invaginations and BCR-microclusters produced by B1-8 B cells over 
20 minute timelapses. We observed that similar numbers of invaginations were 
produced in response to both antigens (Figure 26A). However, the NIP antigens 
stimulated the production of more long-lived invaginations (Figure 26B), greater 
BCR microcluster formation (Figure 26C), and we observed more NIP antigen 
associated with the long-lived invaginations than NP antigen (Figure 26D). These 
results suggest that the reduced levels of BCR microcluster formation in 
response to NP antigen, together with the already reduced strength of the low-
affinity BCR-antigen bond, prevents B1-8 B cells from successful long-lived 
invagination formation, clathrin assembly and antigen internalisation (Chapter 3 
and 4).  
 
 110 
 
 
Figure 26: B1-8 B cells produce more long-lived invaginations, produce microclusters 
faster, and have increased amounts of invagination-associated antigen, when presented 
with NIP antigen over NP antigen 
A) Total number of invaginations tracked from 20 minute TIRF timelapses of B1-8 B cells 
interacting with NIP- or NP-loaded PMS (mean±SEM, n = 25-118 cells over >2 experiments) 
B) Proportion of invaginations with indicated lifetimes tracked from 20 minute TIRF 
timelapses of B1-8 B cells interacting with NP- or NIP-loaded PMS (mean±SEM, n = 25-118 cells 
over >2 experiments). *, p<0.01 in Mann-Whitney test between NP and NIP antigens 
C) Rate of antigen microcluster growth. Antigen microclusters were tracked from 20 minute 
TIRF timelapses of B1-8 B cells interacting with NP or NIP-loaded PMS (mean±SEM, n=9 cells). 
***, p<0.001 in Mann-Whitney test between NP and NIP antigens 
D) Levels of antigen associated with invaginations of indicated lifetimes. Invaginations were 
tracked from 20 minute TIRF timelapse images of B1-8 B cells interacting with NP- or NIP-loaded 
PMS (mean±SEM, n = 25-118 cells over >2 experiments). *, p<0.05 in Mann-Whitney test 
between NP and NIP antigens   
B-D Matlab analysis done by Pavel Tolar 
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5.2.3 Affinity discrimination is mediated by myosin IIA contractility 
In Chapter 4 we observed that myosin IIA generated the force required to 
invaginate the presenting membrane during internalisation of membrane-bound 
antigen. As we have seen that high and low affinity antigens have different 
proportions of long-lived invaginations, we wanted to see if myosin IIA modulation 
affected the ability of B1-8 B cells to discriminate between high and low antigen 
affinities. To do this we inhibited myosin IIA activity in B1-8 B cells using 
blebbistatin treatment and analysed the extent of NP or NIP internalisation from 
the PMS. Interestingly we observed that although the internalisation of both 
antigens was inhibited at high concentrations of blebbistatin, lower 
concentrations seemed to improve internalisation levels of the low affinity NP 
antigen (Figure 27). This suggests that lower concentrations of blebbistatin may 
reduce the force exerted on the BCR-antigen complexes enough to improve the 
low affinity binding between the BCR and NP antigen, which would have quickly 
ruptured under normal myosin IIA activity, thereby increasing the chances of 
internalisation.  
 
Collectively these results show that presentation of antigen by the PMS allows 
discrimination between antigens of different affinities that are indistinguishable in 
solution. High affinity antigen stimulates quicker production of BCR microclusters 
thereby also improving the antigen avidity. Increased affinity and avidity allow the 
formation of stronger and more stable BCR-antigen complexes, better resistance 
against the myosin IIA-generated force and improved internalisation. Therefore, 
these results provide a possible mechanism for how linking mechanical activity to 
antigen internalisation can allow the discrimination of membrane-bound antigen. 
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Figure 27: Modulation of myosin IIA activity affects the ability of B1-8 B cells to 
internalise membrane-bound antigen in an affinity-dependent manner  
B1-8 B cells were treated with the indicated concentration of blebbistatin, and then incubated with 
NP- or NIP- loaded-PMS for 20 minutes at 37°C. B1-8 B cells were fixed before NP/NIP 
internalisation was analysed (means±SEM, n= 25-118 cells over 3 independent experiments). ***, 
p<0.01 in Mann-Whitney test between NP and NIP antigens  
 
5.2.4 Deletion of myosin IIA in B cells prevents B cell development past 
the PrePro B cell stage 
To begin to understand whether the ability of B cells to discriminate between 
antigen affinities was also lost following myosin IIA disruption in vivo, we  
generated mice with a B cell specific deletion of the MyH9 gene.  Mice 
expressing floxed myosin IIA heavy chain (Myh9fl/fl) were crossed with mice that 
expressed Cre recominbase (Cre) under the Mb1 promoter. MyH9 is the only 
myosin IIA heavy chain expressed in lymphocytes therefore this deletion is 
expected to prevent any myosin IIA expression, and the Mb1 gene encodes the 
Igα subunit of the BCR. Thus, at the point of Igα expression, which occurs at the 
very early Pro B cell stage in the bone marrow, Cre is expressed, and myosin IIA 
heavy chain is deleted. Mice need to be heterozygote for MB1-Cre, as 
homozygote mice have no B cells due to loss of Igα expression (Hobeika et al., 
2006).  
 
Before assessing whether or not B cells from these mice (Cre+MyH9fl/fl) are 
impaired in their ability to internalise antigen and discriminate between different 
 113 
antigen affinities, we wanted to assess whether they had a normal B cell 
compartment. We isolated immune cells from the bone marrow, peritoneal 
exudate, inguinal and brachial lymph nodes, and spleen, and identified the B cell 
subsets in these organs using the cell markers shown in Table 1.  
 
Table 1: B cell markers used to identify different B cell subsets harvested from mice  
hi = high levels of expression, lo = low levels of expression, int = intermediate levels of 
expression.  
 
 
 
In the bone marrow PrePro B cell numbers were found to be normal in 
Cre+MyH9fl/fl mice but surprisingly Pro B cells were severely reduced (Figure 
28A) and all subsets of B cells following Pro B cells in the bone marrow, spleen, 
lymph nodes and peritoneal exudate were also reduced by at least 90% 
compared to wild type B cells. This indicates that as soon as Cre+MyH9fl/fl B cells 
express Igα and begin to loose myosin IIA, they can no longer survive and/or 
develop revealing a non-redundant function for myosin IIA at the Pro B cell stage 
(Figure 28). T cell numbers were unaffected in the lymph nodes suggesting that 
the myosin IIA defect was restricted to B cells as expected (Figure 28C). 
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However, T cell numbers were slightly reduced in the spleen (Figure 28B), which 
is likely due to the reduction in spleen size (Figure 29).  
 
Because of the severe reduction in peripheral B cells from Cre+MyH9fl/fl mice, we 
were unable to determine whether any surviving cells had deleted myosin IIA, 
and if they had, whether they were inhibited in their ability to internalise antigen 
and discriminate between antigen affinities, as seen following myosin IIA 
inhibition in vitro. However, we did observe that any Cre+MyH9fl/fl B cells, which 
developed past the PrePro stage were consistently bigger in their size through all 
subsequent developmental stages, suggesting they were physiologically different 
to the wild type B cells and therefore possibly had deleted Myosin IIA (Figure 30). 
To fully assess the role of myosin IIA in antigen extraction and affinity 
discrimination, an inducible deletion in mature B cells will be necessary.  
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Figure 28: Cre+MyH9fl/fl mice have a block in B cell development 
A) Top panel: Absolute B cell numbers flushed from femur and tibia of rear left leg. Cells 
were stained for cell markers for 20 minutes on ice and absolute numbers were analysed using 
FlowJo. Bottom: Representative dot plot showing absence of B cells following the PrePro 
developmental stage. Cells shown were gated on B220hiCD19hi population 
B) Top panel: Absolute B cell numbers and T cell numbers harvested from mashed spleen. 
Cells were stained for cell markers for 20 minutes on ice and absolute numbers were analysed 
using FlowJo. Bottom: Representative dot plot showing absence of follicular and marginal zone B 
cells. Cells shown were gated on B220hiCD93lo population 
C) Top panel: Absolute B cell and T cell numbers harvested from mashed brachial and 
inguinal lymph nodes. Cells were stained for cell markers for 20 minutes on ice and absolute 
numbers were analysed using FlowJo. Bottom: Representative dot plot showing absence of B 
cells but an intact T cell compartment 
D) Top panel: Absolute B cell numbers flushed from the peritoneal cavity. Cells were stained 
for cell markers for 20 minutes on ice and absolute numbers were analysed using FlowJo. 
Bottom: Representative dot plot showing absence of B1 and B2 cells. Cells shown were gated on 
IgMhiCD5int population 
In all panels live B cells were identified as negative for the Live/Dead stain and then B cell 
subsets were identified using the cell markers described in Table 1 (mean±SEM, n= 3-4 mice for 
each genotype). Mice were used at 7-9 weeks of age 
These experiments were done in collaboration with Harold Hartweger. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29: Cre+MyH9fl/fl mice have smaller spleens compared to controls  
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Figure 30: Cre+MyH9fl/fl B cells which develop past the PrePro stage in the bone marrow 
are larger 
A) Cre+MyH9fl/fl (red) and wild type (grey) PrePro B cells. Cells shown were gated on 
B220hiCD19lo  
B) Cre+MyH9fl/fl (red) and wild type (grey) Pro B cells. Cells shown were gated on 
B220hiCD19hiCD2loIgMlo 
Representative plots from 1 of 3 experiments shown in Figure 28 
 
5.3 Discussion 
 
By using PMS as surrogates for APCs, we have demonstrated that B cells 
internalise membrane-bound antigen depending on their affinity.  
 
The antigens used in this study consist of 15 NP or NIP haptens complexed with 
a protein carrier. These antigens have much higher avidity than monomeric 
antigen, therefore, the subtle differences in affinity were masked when exposed 
to B cells in solution (Batista and Neuberger, 2000). However, when these same 
antigens were tethered to the PMS, B cells were able to discriminate between 
their affinities and they internalised the higher affinity antigen to a greater extent. 
By tracking the invaginations and BCR microclusters formed in the B1-8 B cell 
synapse, we saw that B1-8 B cells sustained more long-lived invaginations, 
produced BCR-antigen microclusters faster, and had more antigen associated 
with the long-lived invaginations. These studies support other investigations 
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using PLB as a surrogate for APCs, which show that BCRs have increased 
spreading and signalling in response to higher affinity antigen and suggest that 
affinity discrimination is an intrinsic function of the BCR (Fleire et al., 2006; Liu et 
al., 2010; Wan et al., 2013).  
 
B cells can discriminate between a large range of antigen affinities. Due to the 
bivalency of the BCR and the high avidity nature of most physiologically relevant 
antigens, it is possible that the half-lives of BCR-antigen complexes could reach 
many hours (Batista and Neuberger, 1998). We found that by inhibiting myosin 
IIA contractility and decreasing the mechanical pressure exerted on the BCR-
antigen bonds, the internalisation rate of the low affinity antigens was improved. 
This suggests that under normal conditions, myosin IIA contractility shortens the 
lifetime of the BCR-antigen bonds thereby ensuring affinity discrimination occurs 
over seconds rather than hours and acts as a checkpoint so that only antigens of 
high enough affinity are internalised. Therefore this mechanism could be 
important in preventing the internalisation of lower affinity antigens, which could 
lead to inappropriate B cell activation.  
 
Collectively, these results suggest a model whereby BCRs with a higher affinity 
for the antigens, produce bigger BCR microclusters faster, this together with the 
increased strength of the individual high-affinity BCR-antigen bonds, better 
resists the myosin IIA-generated force, and the invaginations last long enough to 
allow the full assembly of the CCSs and internalisation. In contrast, low affinity 
antigens produce BCR microclusters more slowly, which combined with the 
weaker BCR-antigen interactions, cannot withstand the myosin IIA contractility 
and the bonds rupture, aborting internalisation. This mechanism provides a 
possible link for how the increased B cell signalling in response to high-affinity 
membrane-bound antigen leads to increased antigen internalisation and 
presentation, required for higher levels of T cell help and B cell proliferation to 
ensure a competitive advantage over low affinity antigens in vivo (Khalil et al., 
2012; Schwickert et al., 2011; Shih et al., 2002a; 2002b; Victora et al., 2010).  
 
In vivo, when B cells come into contact with APC-tethered antigen they will also 
see many other signals such as integrin ligands, complement, and other co-
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stimulatory molecules, which may fine tune the B cell response (Carrasco and 
Batista, 2006a; Carrasco et al., 2004; Chan and Brink, 2012; Suzuki et al., 2009; 
Wan et al., 2013). In addition, active forces generated by APCs may also 
influence this process. Therefore, future studies will be necessary to understand 
how various APCs can further regulate antigen extraction and B cell affinity 
discrimination in vivo.  
 
To assess the role of myosin IIA in BCR-antigen internalisation in vivo we 
produced mice with B cell specific deletion of the MyH9 gene and therefore 
myosin IIA (Cre+MyH9fl/fl). However, analysis of B cell responses was not 
possible, as these mice had very few peripheral B cells. The loss of B cells during 
development was observed at the Pro B cell stage in the bone marrow, exactly 
when the Mb1-controlled Cre recombinase is expressed (Hobeika et al., 2006). 
This was not due to loss of Igα, as Igα deficient B cells are arrested at the later 
Pro B cell to Pre B cell transition (Pelanda et al., 2002), therefore supporting the 
finding that the loss of B cells was due to myosin IIA deletion by the Cre 
recombinase. 
 
The loss of B cells in Cre+MyH9fl/fl mice before signalling from the Pre-BCR, 
which occurs at the Pre B cell stage (Figure 4) (Mårtensson et al., 2010; Wang 
and Clark, 2003), indicates a role for myosin IIA in B cell development that is 
separate from its role in BCR-antigen internalisation. Given the important roles 
myosin IIA has in cell biology, there are many possibilities for why loss of myosin 
IIA is incompatible with the survival or differentiation of B cell progenitors. In our 
study we observed that the few Cre+MyH9fl/fl B cells, which made it past the 
PrePro stage, were consistently larger than wild type B cells. This could suggest 
that myosin IIA may be required for cytokinesis during B cell division (Matsumura, 
2005), which would prevent B cells from completing mitosis needed during B cell 
development. However, it is generally thought that B cells do not proliferate until 
exiting the Pro B cell stage and entering the Pre B cell stage, therefore this is 
unlikely to be the sole cause of the defect seen in our studies (Hardy et al., 
1991). This could be resolved by staining the DNA in these cells to understand if 
they have been arrested at the telophase stage of mitosis. Alternatively, the 
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enlarged B cells could be explained by loss of cortical tension, which may 
stimulate cell death due to loss of internal cellular structure and organisation.   
 
Another possible reason for loss of B cells at the Pro B cell stage could be due to 
lack of survival signals. Myosin IIA activity has been shown to be important for 
cell migration and adhesion (Vicente-Manzanares et al., 2009). If Cre+MyH9fl/fl B 
cells were unable to migrate across, or interact with, the stromal cells in the bone 
marrow during development, this could lead to developmental arrest. For 
instance, B cells have been shown to migrate between CXCL12-producing 
stromal cells and IL-7-producing cells during development to receive 
differentiation and survival components (Nagasawa, 2006). So, if the B cells are 
unable to migrate across these stromal cells they may die due to lack of 
appropriate stimulation. It would be interesting in the future to investigate 
downstream signalling in these myosin IIA deficient B cells to understand 
whether they are able to respond to survival signals such as IL-7. Therefore, the 
exact cause for Cre+MyH9fl/fl B cell loss during development will have to be 
addressed by further study.  
 
Independently, to address the question of whether myosin IIA contractility is 
involved in antigen internalisation and affinity discrimination in vivo, MyH9fl/fl mice 
will need to be crossed with mice expressing Cre recombinase under a promoter 
which becomes active only in mature B cells, such as the promoter for CD23, or 
is induced by drug treatment, such as doxycycline. We will then be able to take 
mature B cells from these mice and observe their internalisation and affinity 
discrimination on antigen-loaded PMS in vitro, as well as stimulating B cells in 
vivo to see whether loss of myosin IIA inhibits the ability of B cells to respond to 
antigen in the lymph node.  
 
In conclusion, here we have demonstrated an important role for myosin IIA-
generated force in affinity-dependent antigen internalisation in vitro. The 
understanding of whether this mechanism is still relevant in vivo is still to be 
elucidated and is actively being investigated in the lab.  
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Chapter 6 Conclusions 
 
The aim of this thesis was to investigate and identify novel components and 
mechanisms involved in BCR-antigen internalisation, particularly focusing on 
acquisition of antigen from APCs. Antigen internalisation from APCs has been 
previously shown at the cellular level by intravital imaging. These studies 
demonstrated that in response to immunisation, cognate B cells interact with 
APCs over several minutes, during which they become activated and extract the 
antigen (Carrasco and Batista, 2007; Phan et al., 2007; Qi et al., 2006; Suzuki et 
al., 2009). This antigen extraction and subsequent internalisation is critical for the 
production of T cell-dependent B cell responses. However the molecular 
mechanisms controlling antigen internalisation from APCs are unknown.  
 
To investigate the mechanisms of membrane-bound antigen acquisition, we 
developed a new antigen-presenting substrate from adherent HEK293A cells, 
PMS. These PMS were able to support membrane-bound antigen internalisation 
by B cells in an in an in vitro setting. Live-cell imaging of B cell interaction with 
antigen-loaded PMS revealed that B cells spread over the antigen forming BCR-
antigen microclusters. This spreading was followed by B cell invagination of the 
PMS membrane. The lifetime of these invaginations depended on antigen affinity 
for the BCR and the extent of BCR-antigen microclustering. BCR-antigen 
complexes with sufficient affinity and avidity were able to withstand the ~20 pN 
force exerted by the B cells during invagination formation long enough for 
internalisation to occur.  
 
To identify the pathways controlling this process we used 2 approaches. The first 
was shRNA-mediated knockdown of target proteins in Ramos B cells, and the 
second was inhibition of these proteins using small molecule inhibitors in primary 
Bl6 B cells. Both strategies identified a sequential role for myosin IIA and clathrin 
in antigen extraction and endocytosis.  
 
We then used live-cell TIRF microscopy to visualise the activity of these proteins 
during the internalisation process. These experiments showed that myosin IIA 
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activity peaked immediately before the onset of membrane invagination, whereas 
clathrin was only recruited during the termination of long-lived invaginations.  
 
Comparisons of the internalisation process between antigens of low and high 
affinity revealed that B cells internalised antigen from the PMS in an affinity-
dependent manner. High affinity antigens stimulated faster BCR-antigen 
microcluster formation, more long-lived invaginations, and higher levels of 
invagination-associated antigen, which led to a greater amount of antigen 
internalisation.  
 
Taking these results together we present a model by which, after initial antigen 
binding, B cells spread over the antigen-presenting surface forming BCR-antigen 
microclusters and invaginating the presenting surface in a myosin IIA-dependent 
manner. If an invagination is initiated on a big enough BCR-microcluster with a 
sufficient level of affinity within the BCR-antigen complex, the BCR is able to 
withstand the force generated by myosin IIA and the invagination persists long 
enough for clathrin recruitment and BCR-antigen internalisation (Figure 31).  
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Figure 31: BCR internalisation of membrane-bound antigen
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Therefore, we can conclude that coupling myosin IIA contractility to endocytosis 
permits B cells to internalise antigen in an affinity-dependent manner. This is 
particularly important at the initiation of the immune response in the B cell follicle, 
and during affinity maturation in the germinal centre, when the selective 
expansion of B cell clones depends on the relative amount of antigen internalised 
and presented to cognate T cells (Paus et al., 2006; Schwickert et al., 2011; 
Victora et al., 2010).  
 
The in vitro based studies presented in this thesis of BCR-antigen internalisation, 
gave us an insight into the components and mechanisms involved in BCR-
antigen internalisation in the context of B cell synapses with APCs. However, 
BCR-antigen internalisation has the potential to be highly flexible, making 
investigations into this process difficult. This is supported by studies showing that 
loss of clathrin, actin or lipid rafts, or any other protein identified as mediating 
internalisation, decreased the level of BCR antigen-internalisation but did not 
inhibit it completely, suggesting a high level of redundancy within this process 
(Becker-Herman et al., 2011; Ma et al., 2001; Malhotra et al., 2009a; 2009b; Niiro 
et al., 2004; Stoddart et al., 2002; 2005). This is likely to have evolved as B cells 
are required to recognise and internalise many different possible infections such 
as bacteria, viruses, fungi, and parasites as well as any type of environmental or 
synthetic chemical they may come across, which would suggest a necessary 
level of flexibility in antigen internalisation to be able to accommodate a wide 
variety antigen sizes and shapes (Chan and Brink, 2012).  
 
Different subtypes of B cells themselves may also internalise antigens in different 
ways. For example, memory B cells are likely to recognise antigen with a much 
higher affinity than naïve B cells, and the increase in BCR signalling following 
high affinity antigen binding, may stimulate a different pathway of internalisation 
(Kouskoff et al., 1998; Liu et al., 2010).  
 
Finally studies have shown that molecules on the surface of APCs can fine tune 
and alter the B cell response (Allen and Cyster, 2008; Carrasco and Batista, 
2006a; Carrasco et al., 2004; Lanoue et al., 2002), but the types of co-stimulatory 
molecules can differ in their type and expression between different types of APC, 
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which may also change the way B cells recognise and internalise antigen (Batista 
and Harwood, 2009).  
 
In nearly all of the BCR-antigen internalisation studies done to date with soluble 
antigen, or antigen presented on PLB or PMS, protein antigens with either 
primary naïve B cells or B cell lines have been used. It would be of great interest 
in the future to build on these studies by completing the genetic screen begun in 
the course of this thesis, to put together a molecular pathway for how this 
process occurs in these conditions, and then develop these findings by seeing 
how the molecular requirements can change depending on B cell type, APC and 
antigen used. This would give us a clearer indication for how B cells undergo 
BCR-antigen internalisation and activation in vivo.  
 
Ultimately the knowledge gained from studying BCR-antigen internalisation will 
hopefully contribute to the design and development of immunotherapy and 
effective vaccine design. BCR-antigen internalisation is an intricately controlled 
process that initiates the antibody response. Therefore, inhibition or 
augmentation of this process is an attractive target in the treatment of 
autoimmunity and cancer, or vaccine design, respectively. For example, studies 
have shown that antigens targeted to APCs can boost the effectiveness of 
immunisations (Caminschi and Shortman, 2012), therefore understanding the 
relevance of membrane-presented antigen is likely going to be highly applicable 
in rational design of future vaccines. Similarly, as disruptions in internalisation 
can potentially contribute to the growth of malignant B cells, targeting B cell 
trafficking may also be of therapeutic potential (Davis et al., 2010; Young and 
Staudt, 2013).  
 
These studies signify that by increasing our understanding of BCR-antigen 
internalisation, we can open the door to a range of possible new targets for the 
treatment or prevention of B cell diseases. 
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Appendix – Movie figure legends 	  	  
Movie 1. TIRF timelapse showing B1-8 B cells (unlabelled) spreading over the 
NIP-Qdot (white)-loaded PLB and contracting to form a mature synapse. 
Elapsed time is shown in minutes and seconds. 
 
Movie 2. TIRF timelapse showing Bl6 B cells labelled with αIgM Fab (green) 
spreading and extracting antigen (αIgκ, red) from a PMS. Disappearance of 
antigen from the TIRF view indicates internalisation. Elapsed time is shown in 
minutes and seconds. 
 
Movie 3. TIRF timelapse showing membrane invaginations and antigen 
microclustering in a DiI-stained (fire scale, left panel) and antigen (αIgκ)-loaded 
(green, right panel) PMS, during Bl6 B cell synapse formation. Antigen 
disappearance indicates internalisation. DiI intensity was normalised to the DiI 
image before B cell spreading. Bl6 B cell was unlabelled. Elapsed time is shown 
in minutes and seconds. 
 
Movie 4. TIRF timelapse showing a Bl6 B cell expressing clathrin light chain-
GFP (green) during spreading on an antigen (αIgκ)-loaded PMS (red). Elapsed 
time is shown in minutes and seconds. 
 
Movie 5. TIRF timelapse showing a Bl6 B cell expressing myosin IIA RLC-GFP 
(green) during spreading on a DiD-labelled PMS (red) loaded with antigen 
(αIgκ, no fluorescent label). DiD intensity was normalised to the DiD image 
before B cell spreading. Elapsed time is shown in minutes and seconds. 
 
Movie 6. TIRF timelapse showing a Bl6 B cell expressing LifeAct (green) during 
spreading on a DiD-labelled PMS (red) loaded with antigen (αIgκ, no 
fluorescent label). DiD intensity was normalised to the DiD image before B cell 
spreading. Elapsed time is shown in minutes and seconds. 
